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ABSTRACT OF DISSERTATION 
 
 
 
IDENTIFICATION AND CHARACTERIZATION OF COMPONENTS OF 
THE YEAST SPLICEOSOME 
  
 
The spliceosome is a complex, dynamic ribonucleoprotein (RNP) complex 
that undergoes numerous conformational changes during its assembly, 
activation, catalysis and disassembly. Defects in spliceosome assembly are 
thought to trigger active dissociation of faulty splicing complexes. A yeast genetic 
screen was performed to identify components of the putative discard pathway.  
This study found that weak mutant alleles of SPP382 suppress defects in 
several proteins required for spliceosome activation (Prp38p, Prp8p and Prp19p) 
as well as substrate mutations (weak branch point mutants). This evolutionary 
conserved protein had been found in both yeast and mammalian splicing 
complexes. However, its role in splicing had not been elucidated. This study 
focused on understanding the cellular role of Spp382p in splicing and particularly 
in the discard pathway. Spp382p was found to be essential for normal splicing 
and for efficient intron turnover. Since Spp382p binds Prp43p and is required for 
intron release in vitro, spp382 mediated suppression of splicing factor mutations 
might reflect lowered Prp43p activity. In agreement with this, we find that prp43 
mutants also act as suppressors. This leads us to propose a model in which 
defects in spliceosome assembly, like those caused by prp38-1, prompt 
Spp382p-mediated disassembly of the defective complex via Prp43p Bolstering 
this theory, we find that Spp382p is specifically recruited to defective complexes 
lacking the 5’ exon cleavage intermediate and spp382 mutants suppress other 
splicing defects. 
 I show by stringent proteomic and two-hybrid analyses that Spp382p 
interacts with Cwc23p, a DnaJ-like protein present in the spliceosome and co-
purified the Prp43p-DExD/H-box protein. In this study, I also show that Cwc23p is 
itself essential for splicing and normal intron turnover. Enhanced expression of 
another protein, Sqs1p, structurally related to Spp382p and also found 
associated with Prp43p is inhibitory to both growth and splicing. Synthetic lethal 
and dosage suppression studies bolster a functional linkage between Spp382p, 
Cwc23p, Sqs1p and Prp43p and together, the data support the existence of a 
  
Spp382p -dependent spliceosome integrity (SPIN) complex acting to remove 
defective spliceosomes.  
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CHAPTER 1 
INTRODUCTION 
Most eukaryotic genes have introns that must be properly removed by the 
splicing apparatus to produce translatable mRNA. For many genes, the cellular 
choice of when and where to splice a pre-mRNA is regulated by developmental 
or environmental cues. For instance, current estimates (based on cDNA and EST 
studies) indicate that more than half (50-65%) of all human genes are 
alternatively spliced (Hastings and Krainer 2001). Regulated splicing is required 
to promote much of normal developmental biology and genetic impairment of this 
process accounts for over 100 human genetic disease states (Philips and Cooper 
2000). In all cases studied to date, the regulation of alternative splicing has been 
shown to occur at the level of spliceosome assembly (Valcarcel and Green 
1996). The spliceosome is made up of 5 snRNAs and over 70 proteins (so 
assembly is a complex event) (Brow 2002). By understanding how the normal 
splicing apparatus assembles we hope to provide insight into the nature of the 
enzyme’s active site, the possible steps of regulation, and, ultimately, to offer 
suggestions for therapeutic application.  
 
Splicing and the Spliceosome- An overview 
Pre-mRNA splicing is the nuclear process by which introns are precisely 
removed from cellular pol II transcripts in two transesterification steps within a 
large RNA-protein complex called the spliceosome. In yeast, the spliceosome is 
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composed of five small nuclear RNAs (snRNAs) and over 70 different proteins 
(Brow 2002). Each snRNP in the spliceosome consists of one or two small 
nuclear RNAs (snRNAs), a complement of common proteins and a subset of 
snRNA specific proteins. In vitro, spliceosome formation precedes the chemical 
steps (i.e., RNA cleavage/ ligation reactions) of splicing and involves an ordered 
assembly of the snRNPs on the pre-mRNA (Konarska and Sharp 1986 ; Pikielny, 
Rymond et al. 1986; Cheng and Abelson 1987). Though alternate models have 
been proposed (e.g. the holospliceosome (Stevens, Ryan et al. 2002)), the 
isolation of cellular U2, U5, U6 snRNP complexes (Ohi, Link et al. 2002; Wang, 
Hobbs et al. 2003) and the studies of co-transcriptional pre-mRNA splicing 
(Gornemann, Kotovic et al. 2005; Lacadie and Rosbash 2005) suggest that the in 
vitro studies reflect what is happening in vivo.  
The first clearly defined snRNP association involves recognition of the 5’ 
splice site and the branchpoint region by U1 in an ATP independent manner to 
form the commitment complex (Legrain, Seraphin et al. 1988; Rosbash and 
Seraphin 1991). The commitment complex is then matured by the addition of the 
U2 snRNP at the expense of ATP resulting in the formation of pre-spliceosome. 
Finally, the tri- snRNP (U4/U6.U5) is added as a single particle at the expense of 
ATP to form the “snRNP complete” spliceosome. Once the spliceosome has 
been formed it undergoes structural rearrangements to transform to a 
catalytically active enzyme (Brow 2002). This results in loss (or displacement) of 
U1 and U4 snRNAs from the complex that performs the chemistry of splicing. 
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Chemistry of Splicing 
Pre-mRNA splicing in both yeast and metazoans proceeds via two 
transesterification reactions (Staley and Guthrie 1998; Stevens and Abelson 
2002). In the first reaction, the 2’ hydroxyl group of an internal adenosine located 
within the conserved branch point sequence (UACUAAC in yeast; the underlined 
adenosine is the catalytic residue involved in the first transesterification reaction) 
acts as an attacking nucleophile on the phosphate bond at 5’splice site-exon 1 
junction. This results in the release of exon 1 and formation of the lariat 
intermediate, a structure composed of exon 2 and the circularized intron. In the 
next step, the 3’ –OH of the free exon 1 attacks the phosphate bond at the 3’ 
splice site – exon 2 junction. This results in ligation of the two exons and the 
release of the lariat intron. The excised intron is then typically degraded, the 
spliceosome disassembled and the mRNA exported to the cytoplasm for 
translation. 
 
Sequence requirements  
  Pre-mRNA splicing is a conserved process in eukaryotes, from the 
budding yeast to humans. The consensus elements are related but not identical. 
In yeast, the 5’splice site is G/GUAUGU where as in mammalian consensus 
sequence is G/GURAGU (where R= purine residue and / is the site of cleavage). 
The GU dinucleotide at the 5’ss is conserved in all eukaryotic pre-mRNA. The 
branchpoint consensus sequence, UACUAAC is highly conserved in yeast while 
in mammals it is more variable (YNYURAC, where Y= pyrimidine residue, R= 
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purine residue and the underlined adenosine is the site of branch formation). 
Some mutations in the branchpoint sequences in yeast abolish splicing 
(Jacquier, Rodriguez et al. 1985; Jacquier and Rosbash 1986). In mammals, 
such mutations typically result in use of alternate branchpoint near the 3’splice 
site. A polypyrimidine tract is typically found downstream of the branchpoint and 
upstream of the 3’ splice site in mammalian introns. In yeast, the spacing 
between the branch point and 3’ is variable, ranging from 10 to 155 nucleotides 
(Spingola, Grate et al. 1999). While not well conserved, some yeast introns 
contain a short pyrimidine rich tract of 8-12 nucleotides (mostly uracil) which 
ends one nucleotide upstream of the 3’ splice site. Unlike the case for many 
mammalian introns, this sequence is not required for the first catalytic step in 
yeast splicing (Rymond and Rosbash 1985). However, Guthrie and co-workers 
showed that the presence of a uridine rich tract in yeast enhances the use of the 
3’ splice site when present (Patterson and Guthrie 1991). 
The 3’ splice site consensus is YAG/ (where Y= pyrimidine residue and / is 
the site of cleavage) in both mammals and yeast. The 3’ splice site is 
dispensable for the 5’cleavage and lariat formation in in-vitro (Rymond and 
Rosbash 1985). 
Metazoans also contain a second class of introns that are spliced by the 
‘Minor’ or ‘ATAC’ spliceosome (reviewed in (Tarn and Steitz 1997; Patel, 
McCarthy et al. 2002). The substrates differ in the consensus from the major or 
the abundant class of pre-mRNA in that, the 5’ consensus sequence for them is –
AT/ (/ is the site of cleavage). UAUCCUUU, the branchpoint is longer and more 
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tightly constrained -UCCUUAACU- and the 3’ splice site is YAC (or G) (Hall and 
Padgett 1994). The snRNAs U4, U5 and U6 are common to both classes of 
spliceosomes, however the U1 and U2 from the major class is replaced with U11 
and U12 snRNAs. 
 
DExD/H-box Proteins in Splicing  
The spliceosome undergoes multiple rearrangements (in terms of the 
snRNA- pre mRNA interactions, the snRNA –snRNA interactions and the 
snRNA- protein interactions) during the assembly, catalysis and disassembly 
events that define the spliceosome cycle. These rearrangements require ATP 
hydrolysis and the presence of one of the eight DExD/H proteins (PRP5, SUB2, 
PRP28, PRP5, BRR2, PRP16, PRP22 and PRP43) found in the spliceosome 
(Figure 1.2).  
The DExD/H proteins belong to the helicase superfamily II (SF2), the 
largest helicase superfamily and are defined by the presence of seven motifs (as 
shown in Figure 1.1). The motifs Q, 1a (Walker A motif), 1b (Walker B motif) 
along with motif VI are required for ATP binding and hydrolysis. Mutations in the 
motif III uncouple the ATP hydrolysis from the unwinding, i.e. these mutants are 
capable of hydrolyzing ATP and yet fail to unwind the RNA (Tanner N.K., Cordin 
O. et al. 2003; Linder 2006). For such mutations in the PRP2 and PRP43 genes, 
the proteins are defective in splicing, indicating that both the ATP hydrolysis and 
RNA unwinding activity is essential for the DExD/H box protein function 
(Plumpton, McGarvey et al. 1994; Martin, Schneider et al. 2002).  
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The DExD/H proteins are believed to remodel the spliceosome by 
unwinding the RNA-RNA base pairings or by disrupting the RNA- protein 
interactions or by doing both. Mutational analysis indicated that each protein of 
this set plays a unique and non-redundant role in the spliceosome cycle in vitro 
(Figure 1.2). However, while involvement in specific steps is clear, the 
experiments conducted to date have yet to reveal the details directing substrate 
specificity for this set of splicing factors.  
 
Spliceosome Assembly and DExD/H proteins  
The step that commits the pre-mRNA to splicing is the binding of the U1 
snRNP to the pre-mRNA in an ATP independent process known as commitment 
complex formation. Two separate commitment complex have been defined by in-
vitro gel shift experiments. The first, CC1, requires only 5’ splice site to be 
present on the pre-mRNA, while the second CC2 requires both 5’ splice site and 
branch-point sequences for formation (Seraphin and Rosbash 1989), possibly 
suggesting that CC1 is an intermediate in formation of the more complex and 
slowly migrating CC2. The CC2 band contains Mud2p and branchpoint binding 
protein (BBP) in addition to the U1 snRNPs. The binding of Mud2 and BBP to the 
branch point occurs almost simultaneously and appears to be co-operative 
(Berglund, Abovich et al. 1998). The U1 snRNA protein, Prp40p shows a two- 
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FIG. 1.1. Schematic representation of the DExD/H box helicases. The 7 
motifs of the DExD box helicases are shown below. The DExH box type of 
helicases lack the Q motif. The motifs implicated in ATP binding are colored in 
red, the blue areas indicate regions that interact with the RNA and shaded 
regions in green are those that are important for intra-protein interactions. 
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FIG. 1.2. Schematic representation of the Spliceosome assembly, catalysis 
and disassembly. The colored circles represent the indicated snRNAs along 
with their associated proteins (i.e. snRNPs) which associate with the pre-mRNA 
in an ordered sequence to form the spliceosome. The spliceosome then 
catalyzes the two transesterification reaction resulting in joining of the two exons 
and release of the intron as the lariat. The conformational changes that the 
spliceosome undergoes are believed to be bought about by the DExD/H proteins 
(indicated at the steps they are implicated to act) at the expense of ATP. 
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hybrid interaction with the branch-point protein, Bbp1p (Abovich and Rosbash 
1997), thus implicating the U1 snRNP in recognition of the branchpoint. Mud2p 
binds BBP and with U1 snRNP protein, Prp39p and thus bridging the two ends of 
the intron and facilitating intron definition.  
The U1 snRNA interaction with the conserved pre-mRNA sequences near 
the 5’ splice site is stabilized by Yhc1p, the yeast homolog of the human U1C 
snRNP protein (Zhang and Rosbash 1999). Prp28p, a DExD/H ATPase, is 
implicated in the displacement of the U1 from the 5’splice site, a necessary event 
for later steps in spliceosome assembly involving the U6 snRNP particle. The 
requirement for Prp28p function can be bypassed through mutation of the YHC1 
gene or by mutation of the U1 snRNA gene to weaken it’s association with 
5’splice site. This result suggests that Yhc1p may be the target for Prp28p action 
and that displacing Yhc1p destabilizes the U1 snRNA /pre-mRNA association 
(Chen, Stands et al. 2001).  
After formation of the commitment complex, the U2 snRNP binds to pre-
mRNA in an ATP dependant manner to form the prespliceosome. Curiously, the 
U2 snRNA is 1000 nucleotides longer than its mammalian counterpart (Guthrie 
and Patterson 1988). Complementation of a yeast snr2 (yeast U2) null allele with 
the human U2 snRNA showed that yeast specific U2 snRNA sequence is 
dispensable for growth (Igel and Ares 1988); (Shuster and Guthrie 1988). U2 
snRNP binding to the pre-mRNA requires reorganization of the branchpoint 
region that involves, at a minimum, displacement of the BBP and Mud2 proteins. 
Yeast studies show that this is facilitated by two DExD/H- box proteins, Sub2p 
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and Prp5p (Wells and Ares 1994; Fleckner, Zhang et al. 1997; Xu, Newnham et 
al. 2004). The need for Sub2 protein is bypassed when MUD2, a non-essential 
gene homologous to the mammalian U2AF65, is deleted (Kistler and Guthrie 
2001). This suggests that SUB2 may promote removal of Mud2p in an ATP 
dependant manner. Similarly, removal of the non essential gene, Cus2p renders 
the U2 snRNP binding ATP independent but does not alleviate the need for the 
protein Prp5p (Perriman and Ares 2000; Perriman, Barta et al. 2003). This 
suggests that Prp5p ATPase activity is primarily needed for an internal U2 
snRNP rearrangement step that involves Cus2p (Abu Dayyeh, Quan et al. 2002; 
Perriman and Ares 2007). Prp5p has been suggested to tether U1 and U2 
snRNPs in S. pombe (Xu, Newnham et al. 2004). Recently, our group has 
provided evidence that Prp5p binds with the U2 snRNP protein Hsh155p, 
providing a likely U2 snRNP target in the prespliceosome formation (Wang, He et 
al. 2005). 
The U4, U6 and U5 snRNAs are recruited to the spliceosome as the tri-
snRNP particle. The U4 and U6 snRNAs are the most phylogenetically 
conserved snRNAs in primary sequence and size (Siliciano, Brow et al. 1987); 
(Brow and Guthrie 1988) and are tightly associated within this particle via 
extensive RNA-RNA base pairing. U4 snRNA is not essential for catalysis but 
acts as a chaperone for U6 snRNA. U6 snRNA plays an important role in splicing 
as mutations in U6 can block either the first or the second chemical step of the 
reaction (Fabrizio and Abelson 1990; Madhani, Bordonne et al. 1990). U6 snRNA 
interacts with the 5’ pre-mRNA splice site via its conserved ACAGAG sequence 
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(Sawa and Abelson 1992); (Lesser and Guthrie 1993; Kim and Abelson 1996). 
Mutations in any of these nucleotides result in temperature sensitivity or lethality 
(Madhani, Bordonne et al. 1990). The U6- 5’ splice site interaction is prerequisite 
for U4-U6 unwinding (Li and Brow 1996). The first cleavage and ligation reaction 
occurs only after the dissociation (complete or partial) of U4 snRNA.  
The U5 snRNA, in particular the conserved loop I sequence, has been 
crosslinked in both yeast and mammals to exon sequences near the 5’ and the 3’ 
splice site borders (Sontheimer and Steitz 1993; Newman, Teigelkamp et al. 
1995). This result allows one to speculate that the role of U5 snRNA is to tether 
the exons in order to facilitate the second transesterification reaction. Indeed 
Prp8p, a core U5 snRNP protein, interacts extensively with both the 5’ and the 3’ 
splice site region prior to the second step (Teigelkamp, Newman et al. 1995; 
Umen and Guthrie 1996). Moreover, Prp8p mutants can suppress either 5’ or 3’ 
splice site mutations (Query and Konarska 2004). It is proposed that Prp8p 
functions at the catalytic core of the spliceosome by stabilizing the snRNA/pre-
mRNA interactions needed for the second step of splicing (Collins and Guthrie 
1999); (Grainger and Beggs 2005). 
Throughout spliceosome assembly, structural rearrangements are 
required to configure a catalytically active enzyme.  In addition to the Sub2p and 
Prp5p-dependent steps, these include U1 snRNA displacement from 5’ splice 
site, dissociation of U4 snRNA from the splicing complex, formation of new base 
pairing between U6 and U2, and interaction of the U6 and U5 snRNAs with the 
pre-mRNA substrate. Brr2p is a U5 snRNP specific RNA helicase thought to 
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unwind U4.U6 intermolecular helices (Lin and Rossi 1996); (Kim and Rossi 
1999). Brr2 has RNA dependant ATPase activity in vivo (Raghunathan and 
Guthrie 1998). Brr2 interacts with many other splicing factors in yeast two hybrid 
assay (van Nues and Beggs 2001). This suggest that Brr2 may play a role in 
addition to the U4/U6 snRNA unwinding. Indeed, recent evidence from the Staley 
lab suggests that Brr2p may play a role in both activation and disassembly of the 
spliceosome via the activity of the GTPase, Snu114p (Small, Leggett et al. 2006). 
  Several other proteins also function with the DExD/H-box proteins in 
spliceosome activation. For instance a mutant derivative of Prp38p (prp38-1p), a 
small tri-snRNP protein (28 kDa) with an acidic, serine rich C-terminus, locks the 
fully assembled spliceosome in an inactive state at the restrictive temperature 
(Blanton, Srinivasan et al. 1992);(Xie, Beickman et al. 1998) Since U4/U6 are still 
bound together in this mutant, Prp38p acts as a maturation factor, i.e., the 
spliceosome assemble without Prp38p but arrest in the pre-catalytic stage prior 
to U4/U6 dissociation. Related observations have been made for certain prp8p 
mutants (Kuhn, Reichl et al. 2002). Mutants of another U5 protein, Snu114p, a 
GTPase,  with homology to the ribosome elongation factor EF-2, show 
accumulation of the splicing complex with the U4/U6 still bound together, 
suggesting that this GTPase protein plays a role in the unwinding (Fabrizio, 
Laggerbauer et al. 1997). The effector proteins, Prp38p, Prp8p or Snu114p are 
not helicases (based on absence of canonical helicase motifs), but may recruit or 
activate one such DExD/H proteins in splicing. 
 
 12 
 
 
DExD/H box protein involvement in post-assembly events. 
As discussed above, pre-mRNA splicing proceeds via two 
transesterification steps. Spliceosomes assemble in the absence of Prp2p, but 
Prp2p is required for conformational changes that promote the first cleavage – 
ligation reaction to generate the free upstream exon and the branched lariat 
intermediate (Yean and Lin 1991). While not a stable spliceosomal protein, the 
transient association of Prp2p accompanied by ATP hydrolysis is believed to be 
necessary for the formation of the catalytic core of this enzyme. Prp2p has been 
observed to interact directly with the pre-mRNA (Teigelkamp, McGarvey et al. 
1994) but it remains uncertain how this protein is recruited to the spliceosome or 
how the ATPase activity might be regulated once bound. Intriguingly, Woolford 
and co-workers (Roy, Kim et al. 1995) identified Spp2, a yeast G-patch 
containing protein, in a genetic screen for dosage suppressors of the 
temperature sensitive prp2 mutants. Subsequent work by Lin and co-workers 
(Silverman, Maeda et al. 2004) showed that the Prp2p – Spp2p interaction was 
necessary for the Prp2p association with the spliceosome, leading to the 
hypothesis that Spp2p may direct (or activate) the Prp2p DExD/H protein in the 
spliceosome.  
Prp16p associates with the spliceosome after the first catalytic event and 
promotes this 3’splice site cleavage and formation of the mature message in an 
ATP dependant manner (Schwer and Guthrie 1992). The Guthrie lab has shown 
that Prp16p ATPase activity results in a conformational change that leads to 
protection of the 3’ splice site from RNase H cleavage, and is suggested to 
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enhance the binding of at least 2 proteins (Prp8p and Slu7p) to the 3’ splice site 
(Umen and Guthrie 1995).  
 
Disassembly and DExD/H box proteins 
After activation, the spliceosome performs the two transesterification steps 
and the intron is removed. Once the two exons are joined together, the Prp22 
DExH protein promotes mRNA release (Wagner, Jankowsky et al. 1998). Prp22p 
has been shown to have an earlier role in splicing for transcripts where the 
distance between the branchpoint and the 3’SS is more than 21 nucleotides. For 
such splicing substrates, Prp22p depleted extracts in vitro arrest splicing after the 
first chemical step, resulting in the accumulation of lariat intermediates and free 
exon. However, unlike mRNA release, this function in promoting the second 
transesterification does not require ATP hydrolysis by Prp22p (Schwer and Gross 
1998). 
After mRNA release, the lariat intron is released from the spliceosome 
(through the ATPase activity of Prp43p (Arenas and Abelson 1997); (Martin, 
Schneider et al. 2002). The released lariat intermediate is then linearized by the 
2’-5’phosphodiesterase, Dbr1p (Chapman and Boeke 1991) and subsequently 
degraded. The disassembled snRNPs are then recycled for a new round of 
splicing.  
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Fidelity and DExD/H box helicase  
The removal of introns with single nucleotide precision is generally 
imperative to produce functional mRNA. Yet, how fidelity is achieved by the 
spliceosome is a major unanswered question in the field. Burgess and Guthrie 
found that a single mutation in the helicase domain of the Prp16p DExD/H box 
protein that diminishes its ATPase activity decreased splicing fidelity by allowing 
use of an aberrant branchpoint nucleotide UACUAAC  UACUACC. They 
proposed a “kinetic proofreading” model where splicing fidelity was coupled to 
ATP hydrolysis (Couto, Tamm et al. 1987; Burgess, Couto et al. 1990; Burgess 
and Guthrie 1993). Similar to Prp16p, Prp22p mutants with lowered ATPase 
activity also allow for the use of pre-mRNA substrates aberrant 3’ss substrates 
(Mayas, Maita et al. 2006). Key to this “kinetic proofreading” mechanism is the 
predicted existence of a “discard pathway” that removes defective complexes 
should these persist after the step of ATP hydrolysis. It has been proposed that 
at each ATP driven step, the spliceosome could discard unsuitable substrates via 
the discard pathway (Query and Konarska 2006). Two benefits are envisioned by 
this activity, improved mRNA fidelity through suppression of aberrant splicing and 
the turnover of nonfunctional complexes, the latter being essential since splicing 
complexes are present in limiting amounts. Thus, while the components are 
unknown, such a discard pathway has been speculated to act throughout the 
spliceosome cycle as a quality control system for complex integrity (Konarska 
and Query 2005).  
 15 
 
 
With this in mind, we postulated a simple hypothesis, blocked or stalled 
partially active spliceosomes could be suppressed either by directly enhancing 
their splicing efficiency or by decreasing the ability of the discard pathway to 
recycle them. To address this, I initiated this dissertation project with a genetic 
screen to identify possible effectors of the discard pathway. Rather than using a 
substrate-specific selection approach similar to that which identified PRP16, we 
chose to use a mutation within a core spliceosomal protein that is required for 
pre-mRNA splicing. This approach was reasoned to be much more stringent and 
less likely to identify substrate-specific suppressors. We opted to use prp38-1, a 
mutation in an essential component of the U4/U6.U5 tri-snRNP particle identified 
by our laboratory (Blanton, Srinivasan et al. 1992)). This mutation results in the 
assembly of kinetically impaired spliceosomes that appear to assemble normally 
but splice at a much reduced rate that is exacerbated by elevated temperature 
(Xie, Beickman et al. 1998) resulting in a tight, temperature sensitive growth (and 
splicing) defect. I reasoned that suppressors of prp38-1 might occur through 
increased mRNA synthesis brought about by either direct improvement in 
splicing efficiency or by reduced activity of the proposed discard pathway – 
thereby providing “more time” for the defective spliceosomes to process mRNA 
before dissociation. This model is illustrated in figure 1.3. 
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FIG. 1.3. Hypothetical model for the screen for the discard pathway. In a 
simple model of splicing, the pre-mRNA is either spliced or discarded. One can 
speculate that under normal conditions, the rate of splicing is far greater than the 
rate of spliceosome disassembly and pre-mRNA degradation (Panel A as would 
be the case in a normal wild type cell). However when the spliceosome is 
blocked or stalled, as shown for prp38-1 (panel B), it is likely to be disassembled 
and the pre-mRNA degraded. By extension, increased spliceosome stability is 
expected to increase the likelihood of processing by a partially active complex. 
 
Copyright © Shatakshi Shreekant Pandit 2007
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CHAPTER 2 
MATERIALS AND METHODS 
Yeast genetics and plasmid construction.  
 Yeast Strains 
 Strain Genotype 
MGD353-46D α, ura3-52, trp1-289, leu2-112,113, his 
Ts192 α, ura3-52, trp1-289, leu2-112,113, his, prp38-
1 
prp38-1 Mat A, prp38-1, ura3-52, trp1-289, leu2-112, 
113, his3, arg4 
SPM301 α, ura3-52, trp1-289, leu2-112,113, his, prp38-
1,spp382-1 
MGD353-13D Mat A, trp1-289, ura3-53, leu2-3,112, arg4, 
ade2 
Prp38::KAN, 
YCp50-PRP38 
MatA, ura, leu2, his, prp38::KAN, YCp50-
PRP38 -URA3 
Spp382-1 α, his3∆1,leu2∆0,ura3∆0,spp382::KAN, 
YcpLac111-spp382-2 -LEU2) 
Spp382-2 α, his3∆1,leu2∆0,ura3∆0,spp382::KAN, 
YcpLac111-spp382-2-LEU2 
Spp382-3 α, his3∆1,leu2∆0,ura3∆0,spp382::KAN, 
YcpLac111-spp382-3 -LEU2 
Spp382-4 A/α, his3∆1, leu2∆0, ura3∆0, spp382::KAN, 
p416- ∆spp382- URA3 
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 Spp382-5 α, his3∆1,leu2∆0,ura3∆0 , spp382::KAN, 
YcpLac111-spp382-5 - LEU2 
Spp382-6 A/α, his3∆1,leu2∆0,ura3∆0 , spp382::KAN, 
YcpLac111-spp382-6 - LEU2 
A, his3∆1,leu2∆0,ura3∆0,CLF1-TAP-HIS, 
spp382::KAN, YcpLac111-spp382-6- LEU2 
Spp382-7 α, his3∆1, leu2∆0, ura3∆0, trp1-289,  
spp382::KAN, YcpLac111-Spp382-7 - LEU2 
Spp382-8 Α, his3∆1,leu2∆0,ura3∆0, trp1-289, 
spp382::KAN, YcpLac111-Spp382-8 - LEU2 
Spp382-9 α, his3∆1,leu2∆0,ura3∆0,spp382::KAN, 
YcpLac111-Spp382-9 - LEU2 
GAL1::SPP382 α, his3∆1, leu2∆0, ura3∆0, spp382::KAN, 
pbm150-SPP382 – URA3 
Spp382-TAP A, , his3∆1, leu2∆0, ura3∆0, met15∆0 Spp382-
TAP 
JM640 A, prp8-1(G2347D),his7, ura1, lys2, ade1, 
ade2, tyr1 
JM847 A, prp8-2 (P1015S),his7, ura1, lys2, ade1 
prp43-R242A α ura3-52, trp1-63, his3 ∆200, leu2-1, ade2-
101, ade2-101, lys2-801, prp43::KAN, p358-
prp43-R242A – TRP1 
prp43-H218A α ura3-52, trp1-63, his3 ∆200, leu2-1, ade2-
101, ade2-101, lys2-801, prp43::KAN, p358-
prp43-H218A-TRP1 
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 prp43-S247A α ura3-52, trp1-63, his3 ∆200, leu2-1, ade2-
101, ade2-101, lys2-801, prp43::KAN, p358-
prp43-S247A –TRP1 
prp43-T249A α ura3-52, trp1-63, his3 ∆200, leu2-1, ade2-
101, ade2-101, lys2-801, prp43::KAN, p358-
prp43-T249A- TRP1 
PJ69-4a a trp1-901 leu2-3,112, ura3-52, his3-200, gal4
, gal80 ,  LYS2 : : GAL1–HIS3,  GAL2–ADE2,  
met2 : : GAL7–lacZ 
SPC1 A/α, his3∆1,leu2∆0,ura3∆0, trp1-289, 
cwc23::KAN, pGAL1::CWC23 - URA3 
Cwc23-1 A/α, his3∆1,leu2∆0,ura3∆0, trp1-289, 
cwc23::KAN, YCpLa22-cwc23-1- TRP1 
Cwc23-2 A/α, his3∆1,leu2∆0,ura3∆0, trp1-289, 
cwc23::KAN, YCpLa22-cwc23-2 - TRP1 
Cwc23-3 A/α, his3∆1,leu2∆0,ura3∆0, trp1-289, 
cwc23::KAN, YCpLa22-cwc23-3 - TRP1 
Cwc23-4 A/α, his3∆1,leu2∆0,ura3∆0, trp1-289, 
cwc23::KAN, YCpLa22-cwc23-4 - TRP1 
Cwc23-5 A/α, his3∆1,leu2∆0,ura3∆0, trp1-289, 
cwc23::KAN, YCpLa22-cwc23-5 - TRP1 
Cwc23-6 A/α, his3∆1,leu2∆0,ura3∆0, trp1-289, 
cwc23::KAN, YCpLa22-cwc23-6 - TRP1 
Cwc23-7 A/α, his3∆1,leu2∆0,ura3∆0, trp1-289, 
cwc23::KAN, YCpLa22-cwc23-7 - TRP1 
Cwc23-8 A/α, his3∆1,leu2∆0,ura3∆0, trp1-289, 
cwc23::KAN, pGAL1::CWC23, YCpLa22-
cwc23-8 - TRP1 
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 Cwc23-9 A/α, his3∆1,leu2∆0,ura3∆0, trp1-289, 
cwc23::KAN,  pGAL1::CWC23, YCpLa22-
cwc23-9 - TRP1 
Cwc23-TAP A, , his3∆1, leu2∆0, ura3∆0,met15∆0  Cwc23-
TAP 
Sqs1::KAN Α , his3∆1, leu2∆0, ura3∆0, lys2∆0,  
sqs1::KAN   
 
 
 
 
 
 
 
 
 
 
 
 
Microbial Methods 
E.coli Methods 
E. coli was cultured in 2 x YT medium (1.6% bacto tryptone, 1% bacto 
yeast extract, 0.5% NaCl, pH 7.5) at 37 C with ampicillin (@ 100µg/ mL) added 
when necessary. The strain used for sub cloning and plasmid DNA purification 
was TG1. The cells were made competent by the calcium chloride treatment and 
alkaline lysis was used for small-scale (miniprep) isolation of DNA (Sambrook K. 
J., Fritsch E. f. et al. 1989). 
Yeast Methods 
Yeast cells were routinely cultured at 25 °C in either rich media (1% bacto 
yeast extract, 2% bacto peptone, 2% sugar (glucose or galactose) or in selective 
drop out media as indicated. Yeast transformation was done by the lithium 
acetate method of Ito et al. (Ito, H., Fukuda, Y. et. Al. 1983) with the isolation of 
transformants on selective media (Sherman F., Finks G. R. et al. 1986).  
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For generating double mutants, the indicated strains were crossed and the 
diploid selected on a drop out medium that selects against the individual haploid 
parents. Then meiosis was induced by growth on nitrogen-limited sporulation 
medium. The tetrads were dissected using an Olympus BH2 microscope fitted 
with a micromanipulator as described by Sherman et al (Sherman F., Finks G. R. 
et al. 1986). The meiotic offspring from at least 20 tetrads were scored for 
genotypic markers on drop out media and for mating type by crossing to tester 
strains (see Strain List) and selecting for the resultant diploid on selective drop 
out media. The presence of specific chromosomal KANR knockouts was checked 
by growth in YPD with G418 (concentration of 200 mg/liter) and by direct PCR 
analysis of the mutant allele. For other mutants, the defective allele was 
confirmed by sequencing the PCR product, scoring for a restriction site 
polymorphism, and by complementation with the corresponding wild type allele. 
Mutants were checked for altered growth by streaking cultures at 19, 23, 30, 35 
and 37 °C along with controll mutant and wildtype strains.  
Yeast two-hybrid analyses were conducted by insertion of full-length open 
reading frame (ORF) PCR fragments (See Primer List) into the GAL4 activation 
domain plasmid pACT and the GAL4 DNA binding plasmid pAS2 (Clontech 
Laboratories Inc., Palo Alto, CA). For all the clones, except  PRP43, PCR 
products were digested with BamH1 and ligated to the pAS2 (BamH1 digested) 
or pACT (BglII digested) vectors. For the pAS2-PRP43 construct, the YCpLac33-
PRP43 subclone was digested with Xba1/Pst1 and the PRP43 containing 
fragment and isolated from an agarose gel using a Qiagen DNA Purification Kit. 
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This DNA was then ligated to a pAS2 Xba1/Pst1 digested vector. For all 
constructs, reporter gene transactivation was scored in yeast strain PJ69-4A. 
Unless otherwise noted, two hybrid growth results were compared after 3 days 
growth at 30°C on medium lacking adenine and on histidine-deficient medium 
supplemented with 5 or 20 mM 3-aminotriazole as described previously (James, 
Halladay et al. 1996). 
For the checking the cis suppression, the spp382-1and  spp382-6 
transformed with the reporter plasmids were patched and grown on a minimal 
plate lacking uracil at room temperature for two days. After two days, a 5 ml 
solution of X-Gal agar solution  was overlayed onto the plate as reported in CSH 
Manual with the Magnesium and Phosphate concentrations adjusted to 5X the 
standard plate concentration to allow for the normal diffusion of the 5 ml overlay 
buffer/salts mix to the rest of the plate. The plates were incubated at room 
temperature for 16 hours and scanned. 
 
Yeast Suppressor Screen  
Spontaneous suppressors of the prp38-1 mutant strain, ts192 (Blanton, 
Srinivasan et al. 1992) were selected by growth at 37 °C on rich medium (YPD 
(Chen, Frand et al. 1998)). Colonies were backcrossed to the wildtype strain, 
MGD353-13D, sporulated, and the resultant offspring scored for the 
reappearance of temperature sensitivity expected when the mutation is due to an 
extragenic suppressor. To test for dominance, the isolated suppressors were 
 23 
 
 
mated to the prp38-1 haploid yeast strain SP101 and the diploid assayed for 
growth at 37 °C.  
The wildtype SPP382 allele was isolated by transforming SPM301 with a 
centromeric yeast DNA library (Rose, Novick et al. 1987) and screening replica 
plates of the transformants for the re-acquisition of temperature sensitivity. A 
PCR and sub-cloning approach (vector YCplac33 (Gietz and Sugino 1988)) was 
used to identify SPP382 as the relevant gene. (See Primer List for primer 
sequences for Ylr424w-1 and Ylr4242w-4).  
Linkage analysis was used to confirm that the recovered gene, SPP382, 
was the wildtype allele of the original mutation and not an unlinked low dose 
suppressor. A PCR product containing the SPP382 orf and 500 base pairs of 
upstream sequence was cloned into the BamH1 site of YIpLac211, an integration 
vector. The resultant plasmid was cut at a unique site (Hpa1) within the insert to 
direct integration to homologous chromosomal locus. The parent suppressor 
strain, SPM301, was transformed with the linearized DNA resulting in a Ura+, 
temperature sensitive strain. The site of integration was checked by Southern 
blot analysis using radiolabeled SPP382 gene fragment as a probe. This 
transformed strain was mated to a wild type (MGD353-13D) and the resulting 
diploid sporulated. Meiotic progeny from 21 tetrads were scored for temperature 
sensitivity and segregation of the URA3 marker.  
The wildtype allele of a second suppressor, AAR2, was identified by 
complementation of SPE401 using 133 genes related to RNA processing (Listed 
in Table 1) selected from an ordered set of yeast genes expressed with a GAL1 
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promoter. Each transformant was then screened for temperature sensitivity. 
Added support that the recovered gene encodes the suppressor allele was made 
by DNA sequence analysis of the mutant allele. 
 
Mutagenesis 
Site directed mutagenesis was done by inverse PCR with mutagenic 
oligonucleotides (sequences in the Primer List) and the Expand Long polymerase 
(Roche Biochem). The target genes were (a) the SPP382 orf plus 450 bp of 5’ 
flanking sequence (amplified using primers Ylr424w-1 and Ylr24w-2, see Primer 
list for Spp382) subcloned into the BamH1 site of the plasmid,YCPlac111 (Gietz 
and Sugino 1988) and (b) the CWC23 orf plus 100 bp of 5’ and 100 bp of 3’ 
flanking sequence (amplified using primers cwc23-1 and cwc23-2, see Primer list 
for the rest) cloned into BamH1 site of YCpLac22 (58). Random mutagenesis of 
the CWC23 orf was done with the Mutazyme enzyme (Stratagene) and ORF 
specific primers (See Primer List). The mutated CWC23 orf was used as a mega 
primer to amplify a full length YCpLac22-CWC23 plasmid following the 
manufacturer’s protocol (Stratagene). In all cases, plasmids containing the 
mutated gene were transformed into yeast where the corresponding 
chromosomal allele was replaced with the Kanamycin resistance gene and a 
second plasmid was present bearing a wild type allele linked to URA3 selectable 
marker. After isolation of the double transformant, the wild type copy was 
shuttled out by growing the strain on 5 flurooratic acid (Bender and Pringle 1991). 
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The mutagenized gene was then scored for lethality (failure to grow on the FOA 
plates) and for temperature or cold sensitivity at 19, 25, 30, 35 and 37 C. 
For generating the GAL1::spp382-4 promoter fusion strain, SPP382 was 
amplified with primers Ylr424w-1 and Ylr424w-4 (see Primer List below), the 
PCR product was digested with Cla1, gel purified and blunt ended with T4 DNA 
Polymerase (New England Biolabs), phosphorylated, and then ligated into the 
Sma1 site of the GAL1 yeast expression vector, p416 (Mumberg, Muller et al. 
1994). The plasmid was transformed into a spp382::KAN / SPP382 heterozygous 
diploid yeast strain the desired haploid strain obtained after sporulation as 
described above. 
 
 RNA Methods. 
Northern Analysis: Total cellular RNA was recovered from yeast grown 
under permissive or non-permissive conditions (for temperature or sugar source) 
and assayed by northern blot from a 1% agarose/formaldehyde gel as described 
by Sherman et. al (Methods in Yeast Genetics). The snRNAs were resolved on a 
5% polyacrylamide, 7M urea denaturing gel and electroblotted to a Nytran 
membrane prior to hybridization. Uniformly radiolabeled 32P probes were made 
with the indicated templates using the Random Primer labeling kit (Invitrogen) 
following the manufacturer’s protocol. The RNA bands were visualized with 
Typhoon 8600 phosphorimager (GE Biosystems) and, where, indicated 
quantified with ImageQuant software. 
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Primer Extension Analysis:  The yeast strains transformed with the 
intron-bearing GAL1-RPS17 fusion gene on plasmid HZ18 (Teem and Rosbash 
1983) were cultured in media lacking uracil with galactose as the carbon source. 
Total RNA was isolated as described above. A 5’ end labeled oligonucleotide 
complementary to exon 2 (RB1 (see primer list), (Teem and Rosbash 1983) was 
used for primer extension with reverse transcriptase (Promega) as described by 
Rymond et al (Rymond, Pikielny et al. 1990). The cDNA products were resolved 
on a 5% polyacrylamide, 7M urea denaturing gel and visualized with the Typhoon 
8600 phosophoimager. 
In Vitro Splicing Assay and Spliceosome Assembly: Splicing reactions 
and spliceosome assembly were performed essentially as previously described 
(Pikielny, Rymond et al. 1986). Splicing reactions were assembled on uniformly 
radiolabeled pre-mRNA prepared from EcoRI cleaved SPRP51A DNA (renamed 
RPS17A) by in vitro transcription using SP6 RNA polymerase. The reactions 
were resolved on 5% polyacrylamide, 7M urea denaturing gel gels and the bands 
were visualized using the Typhoon 8600 phosphorimager.  
Co-immunoprecipitation of snRNAs: 20 µl of the SPP382-Tap whole 
cell extract (see below) was mixed in a siliconized microfuge tube with 150 µl of 
buffer A [150 mM KCl, 2 mM Mg(OAc)2, 50 mM HEPES, pH 7.5] and 20 µl of 
rabbit IgG agarose beads (Sigma) for 2 hours at 4oC. The beads were recovered 
by brief low-speed centrifugation (2,000 RPM, 1 minute), and washed 6 times 
with 800 µl of the Buffer A. The snRNAs were then released by the addition of an 
equal volume of 2× PK buffer (200 mM Tris-HCl pH 7.5, 25 mM EDTA, 300 mM 
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NaCl, 2% SDS, 2 mg/ml proteinase K) and incubating for 10 min at 37°C. The 
samples were then phenol extracted, the snRNAs ethanol precipitated and 
resolved on a 5% polyacrylamide, 7M urea denaturing gel which was blotted and 
hybridized as indicated above. 
SnRNP analysis: The native snRNP complexes present in yeast splicing 
extracts were resolved on 4% polyacrylamide (80:1 acrylamide::bisacrylamide)-
0.5% agarose gels run in 50 mM Tris-glycine buffer (pH 8.8) overnight at a 30-V 
constant voltage and then electroblotted to a Nytran membrane. The snRNPs 
were visualized by hybridizing the membrane with snRNA specific radiolabeled 
probes. 
Protein Purification and Mass Analysis.  
Splicing extracts were prepared under liquid nitrogen with a Spex 
Certiprep 6850 freezer mill as published (Wang, He et al. 2005). TAP- tagged 
Spp382 was purified from 20 liters of cells by IgG agarose and calmodulin 
agarose affinity selection using standard procedures (Puig, Caspary et al. 2001) 
with NaCl increased to 450 mM in the binding and wash steps. The proteins 
released from calmodulin agarose were then resolved by two dimensional liquid 
chromatography followed by mass analysis with a Deca mass spectrometer 
(ThermoFinnigan) as described (Wang, Hobbs et al. 2003). The mass-intensity 
lists were screened against the non-redundant NCBI protein database with 
MASCOT software at the default cutoff score of 20.  
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In vivo labeling and TAP purifications  
Yeast proteins were 35S labeled by the addition of 1 mCi of Trans-35S (ICN) 
to 1 ml of yeast concentrated from 10 ml of culture (at an optical density at 600 
nm of 1.0) grown in low sulfur medium. The cells were incubated with the labeled 
amino acids at 30°C for 3 hr and harvested as described in Wang et al (Wang, 
Hobbs et al. 2003). TAP purification was then performed scaled down for use 
with the reduced volumes as recently described (Wang and Rymond 2003). 
Where indicated, the NaCl concentration was adjusted to 150, 300, or 500 mM 
during the binding and wash steps of protein A agarose chromatography. 
Proteins were precipitated with 6% trichloroacetic acid and the samples resolved 
on a sodium dodecyl sulfate-5 to 10% gradient polyacrylamide gel with 
Benchmark molecular weight markers (Invitrogen). The labeled bands were 
visualized with a Typhoon 8600 phosphorimager.  
Western blotting 
Western transfers of the TAP extracts on nitrocellulose membrane were 
blocked for half an hour in 5% milk (in PBS) and then incubated for 2 hours with a 
1:1,000 dilution of rabbit anti-peroxidase primary antibody (Sigma) followed by 
incubation for 1 hour with a 1:1,000 dilution of goat anti-rabbit immunoglobulin G 
(IgG) (heavy-plus-light chain)-alkaline phosphatase secondary antibody 
(Gibco/BRL). The membranes were then developed with 5-bromo-4-chloro-3-
indolylphosphate-nitroblue tetrazolium according to the supplier's 
recommendation.
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Spp382p depletion 
To deplete Spp382p in vivo, GAL1::spp382-4 yeast strain was grown at 
25°C in YP broth with 2% galactose to an optical density at 600 nm of 
approximately 0.20. The yeast were then harvested by centrifugation and 
resuspended in 2x the original culture volume with YP broth containing 2% 
glucose. The culture was incubated at 37°C for 16 h prior to extraction of RNA or 
the preparation of yeast whole cell extract as described above. 
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Primer List For Spp382: 
Ylr424w-1 CGG GAT CCC AAT GCC TTCCTT TAA 
AAT 
~450 bp upstream 
Ylr424w -2 GCG GAT CCT GAG GTC AAG GGC 
CCA TAA ATA 
-stop codon, end of 
gene. 
Ylr424w -3 GGA TCC ATG GAG GAT TCG GAC 
TCC AAC 
@ start site, for 
GAL1 construct 
Ylr424w -4 GGA TCC TAG AGG TCA AGG GCC 
CAT AA 
@ end of gene 
Spp382dn TTG GAA ACA TTT CAA GGG CAA 50 bp  downstream 
Ylr424w -5 TAG TAC AAC CGA GAG AGG TCG 50 bp upstream 
Ylr424w -6 CCC GAT AAA ACT TAG CAC TTG Middle  start 
Ylr424w -7 ATC GAC AGC GCT ATC ACC CTA middle  end 
Ylr424w -8 CCG GAT CCT CAT GGA GGA TTC 
GGA CTC CAA 
Forward for two 
hybrid 
Ylr424w -9 GTT TTA GGC GAA GCG TTG TTA  Middle to end 
Ylr424w -10 GTC ATA TCA AAC CCT TCC CAA AA Middle to start 
Ylr424w -11 AAG ATT GGT GCT ATT TTA AAA middle  end 
Ylr424w 12 GCT CGA GTA TCT ATC CGA TTG Middle  start 
Ylr424w -13 AAA GAC TTA ACC TCC AAT GAA For allele detection 
Ylr424w -14 GAA GAC TTA ACC TCC AAT GAA For allele detection 
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Primer List For The Rest: 
Cwc23-1 CCC GGA TCC TC ATG CCA GGA 
CAC GAA TTG 
Forward for two hybrid
Cwc23-2 CTA GGA TC CTA GTC GAG TAG 
GAT AGG TTC 
Reverse for two hybrid
Cwc23-up CCC AAG CTT GCA TAT TAT CTC 
GCA 
100 bp upstream 
Cwc23-dn GGC GGA TCC TTT CCT TTT CTT 
TTT CTT 
100 bp down stream 
Prp43-1 ATC AAG ATC TCA ATG GGT TCC 
AAA AGA AGA TTC 
Forward for two hybrid
Prp43-2 CTA TAG ATC TCT ATT TCT TGG 
AGT GCT TAC TC 
Reverse for two hybrid
Ynl224c-1 CCC GGA TCC TAA TGG CAA AAA 
GGC ATA 
Forward for two hybrid
Ynl224c-2 CCC GGA TCC GTG TAT ATT ACC 
ATA GAT 
Reverse for two hybrid
Aar2-1 CCC GAA TTC GAA TGG TAA ACA 
TTT GGT 
400 bp upstream 
Aar2-2 CCC AAG CTT GAT ACA TCC CTT 
AAC CAT 
200 bp down stream 
Aar2-3 CCC GGA TCC TAA TGA ATA CTG 
TAC CAT TT 
Forward for two hybrid
Aar2-4 CCC GGA TCC TTA TGG CCT TTG 
GTA ATA 
Reverse for two hybrid
RB1 CGC TTG ACG GTC TTG GTT C For primer extensions 
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Site Directed Mutagenesis Primer List: 
Spp382-3: ANN GTT GCG GGA AAA GGC CTT 
Spp382-4: TCC CAT ACT CGA AAG TAA CTT 
Spp382-A2: GCT GCA GCT ATT GAA GCA AAA TTT 
Spp382-A2R: AAT TGT GTC TTT GAT CTT ATC GTC 
Spp382-A3: GCT GCA GCT TTC GAT TTG AGA CAG 
Spp382-A3R: TAA TGT AGA TTT ATC AAG GTG GTA 
Spp382-L232: GCC CTT TCT GAA TTG GAG GTT 
ACT 
Spp382-L232R: CCT CTC TTG TCC ATA ATA TTC 
TTT 
Cwc23-H1: CAA CCT GAC AAA CAC CCG GAC 
Cwc23-H2: CAG CCG GAC AAT CCA TCA ATT 
Cwc23-H2r: TTT GTC AGG ATG ATA CTT CAG 
Cwc23-H3: CAA CCT GAT TTA TTG CAA ATC 
Cwc23-H3R: TGG TGT GGT GGT GGG TAT CGT 
Cwc23-F65: TTA CAC TTA TTA TCG ACC GCA 
Cwc23-F65R: TTT GTG TAT AAT TGA TGG ATT 
Cwc23-A1: GCG GCC GCT AAA TAC AGG ACC CTT 
Cwc23-A1R: TTG GGG CAA ATC ATC GTA GAT GGT 
Cwc23-A2: GCG GCC GCT AAA CAC CCG GAC AAT 
Cwc23-A2R: ATA CTT CAG GGC AAG GGT CCT GTA 
Cwc23-A3: GCG GCC GCT AAT AAT AAA TCA AAC 
Cwc23-A3R: GAA GTT GTC AAG GAC AAT TCT CAA 
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List of splicing factors used for over expression. 
42 PRP8 YHR165C 
43 PRP9 YDL030W 
44 PRP11 YDL043C 
45 PRP16 YKR086W 
46 PRP19 YLL036C 
47 PRP21 YJL203W 
48 PRP22 YER013W 
49 PRP24 YMR268C 
50 PRP28 YDR243C 
51 PRP31 YGR091W 
52 PRP38 YGR075C 
53 PRP39 YML046W 
54 PRP40 YKL012W 
55 PRP42 YDR235W 
56 PRP43 YGL120C 
57 PRP46 YPL151C 
58 RDS3 YPR094W 
59 RPL30 YGL030W 
60 SAD1 YFR005C 
61 SKY1 YMR216C 
62 SLU7 YDR088C 
63 SMB1 YER029C 
64 SMD1 YGR074W 
65 SMD2 YLR275W 
66 SMD3 YLR147C 
67 SME1 YOR159C 
68 SMX2 YFL017W-A 
69 SMX3 YPR182W 
70 SNP1 YIL061C 
71 SNT309 YPR101W 
72 SNU13 YEL026W 
73 SNU56 YDR240C 
74 SNU66 YOR308C 
75 SNU71 YGR013W 
76 SNU114 YKL173W 
77 SPP2 YOR148C 
78 SPP381 YBR152W 
79 SPP382 YLR424W 
80 SUB2 YDL084W 
81 SYF1 YDR416W 
No Gene ORF 
1 AAR2 YBL074C 
2 BRR1 YPR057W 
3 CBC2 YPL178W 
4 CDC40 YDR364C 
5 CEF1 YMR213W 
6 CLF1 YLR117C 
7 CUS1 YMR240C 
8 CUS2 YNL286W 
9 CWC2 YDL209C 
10 CWC15 YDR163W 
11 CWC22 YGR278W 
12 CWC25 YNL245C 
13 DIB1 YPR082C 
14 ECM2 YBR065C 
15 EXO84 YBR102C 
16 HSH49 YOR319W 
17 GSP1 YLR293C 
18 IST3 YIR005W 
19 ISY1 YJR050W 
20 LEA1 YPL213W 
21 LSM2 YBL026W 
22 LSM3 YLR438C-A 
23 LSM4 YER112W 
24 LSM5 YER146W 
25 NAB2 YGL122C 
26 LSM7 YNL147W 
27 LSM8 YJR022W 
28 NTF2 YER009W 
29 LUC7 YDL087C 
30 MER1 YNL210W 
31 MSL1 YIR009W 
32 MSL5 YLR116W 
33 MUD1 YBR119W 
34 MUD2 YKL074C 
35 NAM8 YHR086W 
36 NTC20 YBR188C 
37 PRP2 YNR011C 
38 PRP3 YDR473C 
39 PRP4 YPR178W 
40 PRP5 YBR237W 
41 PRP6 YBR055C 
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122 YRA2 YKL214C 
123 NAB6 YML117W 
124 NUG1 YER006W 
126 SQS1 YNL224C 
127 ASC1 YMR116C 
128 DCP2 YNL118C 
129 HRT2 YOL133W 
130 MEX67 YPL169C 
131 RIF2 YLR453C 
132 GLE2 YER107C 
133 CSE1 YGL238W 
82 SYF2 YGR129W
83 USA1 YML029W 
84 YHC1 YLR298C 
85 YJU2 YKL095W 
86  NTR2 YKR022C 
87   YLR132C 
88 LSM1 YJL124C 
89 CWC23 YGL128C 
90 BUD13 YGL174W 
91 BuD31 YCR063W 
92 PML1 YLR016C 
93 GCN2 YDR283C 
94 CDC33 YOL139C 
95 DHH1 YDL160C 
96 HTA1 YDR225W 
97 IMG1 YCR046C 
98 MRP7 YNL005C 
99 MRP13 YGR084C 
100 RVB2 YPL235W 
101 KRS1 YDR037W 
102 TOS4 YLR183C 
103 ERB1 YMR049C 
104 LIN1 YHR156C 
105 UTP21 YLR0409C
106 YMC6 YML025C  
107 NPL3 YDR432W 
108 SRB2 YHR041C 
109 YEF3 YLR249W 
110 TIF4631 YGR162W
111 TIF4632 YGL049C 
112 BUR2 YLR226W 
113 KAP95 YLR347C 
114 MSH4 YFL003C 
115 NAB3 YPL190C 
116 NRD1 YNL251C 
117 SCP160 YJL080C 
118 SGV1 YPR161C 
119 SRO9 YCL037  
 120 SRP1 YNL189W 
121 AIR2 YDL175C 
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CHAPTER 3 
RESULTS 
Identifying extragenic suppressors of the prp38-1 spliceosome maturation 
mutant. 
Spontaneous suppressors of the prp38-1 ts growth defect were selected 
on YPD medium at the non-permissive temperature of 37 °C. Spontaneous 
suppressors were found at a rate of roughly one per 1 X 106 cells plated. In total, 
101 yeast strains were isolated that formed colonies after 2-3 days at 37 °C.  
In principle, suppressor strains might harbor mutations within prp38-1 (i.e., 
intragenic suppressors) or within another gene (i.e., extragenic suppressors). To 
define the subset of extragenic suppressors each strain was backcrossed to wild 
type yeast and the resulting meiotic offspring scored for temperature sensitivity. 
Unlinked extragenic suppressors will segregate from the original prp38-1 allele 
and, as a consequence, ts mutants reappear in the meiotic offspring. Of the 101 
suppressors analyzed this way, 11 are extragenic and the remaining 90 most 
likely represent second site mutations within (or reversion of) prp38-1.  
 Extragenic suppressor mutations might result from loss of function and be 
recessive in nature or from gain of function and be dominant alleles. To 
distinguish between these possibilities, the extragenic suppressor set was mated 
to a strain of opposite mating type bearing the original prp38-1 mutation (see 
strain list in Materials and Methods). The resultant diploid strains are 
homozygous for the prp38-1 mutation and heterozygous at the suppressor locus. 
Each strain was tested for growth at the restrictive temperature. If the suppressor 
 36 
 
 
allele is dominant, then the diploid strain will form colonies at the temperature 
non-permissive for prp38-1. In contrast, recessive suppressor mutations will be 
masked in the heterozygous state and not support growth. All eleven extragenic 
suppressor strains failed to grow at 37oC indicating that each resulted from a 
recessive suppressor allele.  
Since the suppressor alleles are recessive, candidate suppressor genes 
could be identified by scoring for reacquisition of the ts phenotype after 
transformation with a wild type gene copy. I used two of the “best” suppressors 
(based on the colony size of the suppressed strain) for the initial gene isolation.  
I transformed the suppressor strain M3 with a yeast genomic DNA library 
prepared from wild type yeast (Figure 3.1). Transformants from a single-copy 
(centromeric) plasmid library were selected by complementation of a plasmid-
linked nutritional marker (URA3) at the permissive temperature (23°C) and then 
screened by replica plating on nutrient rich medium at 37°C. In total, 
approximately 30,000 plasmid transformants were screened. Two plasmids were 
recovered from yeast that, by the replica plate assay, reacquired temperature 
sensitivity.  
While the yeast used for plasmid recovery clearly showed the ts 
phenotype, it was possible that this was due to a spontaneous mutagenic event 
in the transformant rather than the desired plasmid-linked event. In order to 
address this, I recovered plasmids from yeast, amplified these in E.coli and re-  
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FIG. 3.1 spp382-1 is a recessive, extragenic suppressor of the spliceosome 
maturation mutant, prp38-1. Growth of wild type yeast (1, 5), an otherwise 
isogenic prp38-1 (ts192) mutant (2, 6), and the suppressed mutant (3, 4) on rich 
media after 3 days at the permissive temperature (23 °C) or two days at the 
restrictive temperature (37 °C). In streaks 4-6, a centromeric yeast plasmid with 
the wild type SPP382 gene (pSPP382) is co-expressed. 
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transformed the each of purified DNA back into the original suppressor strain 
(M3). Only one of the two recovered plasmids resulted in all the secondary  
transformants showing the reacquisition of the temperature sensitive phenotype, 
demonstrating a plasmid-dependent event. I noted that transformation of this 
same plasmid into a wild type strain did not change its growth characteristics at 
either 23 °C or 37 °C (Figure 3.1). Confirmatory results for plasmid linkage of the 
ts phenotype were obtained by counterselecting for plasmid loss from the 
secondary transformants by growth in the presence of the anti-metabolite, 5-
fluroorotic acid (Boeke, LaCroute et al. 1984). As predicted based on linkage, 
plasmid loss resulted in colonies which were no longer temperature sensitive. 
Thus, the identified plasmid (but not a control plasmid assayed in parallel) was 
sufficient to block the recessive suppressor phenotype and thus contained a 
yeast gene that might encode the wild type allele of the suppressor locus.  
The candidate plasmid was sequenced to find out which chromosomal 
region it contained. The DNA fragment had two ORFs (ATG17 and an unknown 
open reading frame, YLR424w) from chromosome 12. ATG17 codes for a non-
essential scaffold protein that plays a role in pre-autophagosomal structure 
organization (Kabeya, Kamada et al. 2005) and seemed to be unrelated to 
splicing. On the other hand, we and others had observed the YLR424w gene 
product in splicing complexes (Gavin, Bosche et al. 2002); (Wang, Hobbs et al. 
2003) making this the likely candidate. This gene was sub-cloned using PCR into 
a centromeric plasmid. Transformation of this clone into the naïve M3 strain 
resulted in reacquisition of temperature sensitivity (Figure 3.1). Confirmation that 
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this was the suppressor-defined gene was made by linkage analysis which 
established that the cloned DNA was inseparable from the original suppressor 
locus (see Materials and Methods). I also sub-cloned ATG17 from the original 
library plasmid using restriction enzymes and transformed into the original 
suppressor strain. No loss of suppression was observed with this gene, 
establishing YLR424w and not ATG17 as the suppressor gene.  
Reduced Spp382p activity suppresses the prp38-1 defect. 
SPP382 was reported as essential in the systematic analysis of yeast 
gene function study (Giaever, Chu et al. 2002) but Spp382p’s role, if any, in 
cellular splicing was undetermined. To investigate this, I tested a series of site-
directed mutations in residues conserved in the yeast, human, zebra fish, fruit fly 
and nematode homologs (Altschul, Madden et al. 1997) for biological activity 
(Figure 3.3 A). The plasmid borne spp382 mutants were scored for 
complementation of the null spp382::KAN allele after plasmid shuffle removal of 
a URA3-linked wild type copy of this gene (Figure 3.3 A). SPP382 encodes a 
conserved 708 amino acid protein that contains a G-patch motif common to a 
number of RNA binding proteins (Figure 3.2 B) (Aravind and Koonin 1999; 
Silverman, Maeda et al. 2004; Tsai, Fu et al. 2005; Herrmann, Kais et al. 2007). 
Changes in the G- patch domain either prove lethal (spp382-9 or spp382-10) or 
impair growth (spp382-2 and spp382-3) consistent with this being a critical motif 
(Fig 3.3 B and Table 3.1). A small deletion within the central domain results in a 
tight ts mutant (spp382-5). Mutants bearing triple alanine substitutions near the  
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FIG. 3.2. Alignments of the G-Patch and Spp382p protein. A. Alignment of 
Spp382p homologs showing conservation of the protein across species. The 
abbreviations used are C.e – Caenorhabditis elegans, D.r – Danio rerio, H.s – 
Homo sapiens, D.m. Drosophila melanogaster, S.c - Saccharomyces cerevisiae.  
B. Alignment of G-patch motif with the consensus below. The sequences are 
named using the notation Protein name _ Species abbreviation_Gene Bank GI 
(Gene identification number). Abbreviations used Sc - Saccharomyces 
cerevisiae, Hs - Homo sapiens, Sp -Schizosacchromyces pombe, Ca -Candida 
albicans, At - Arabidopsis thaliana. 
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A                                                      
D.r.   1 MSMSHLYGRRGDEEEEDGVEIEKFEVSEWDLANEFNPDRRRYRQTKEEATYGIWAEQDSD 
60 
H.s.   1 MSLSHLYRDGEGRIDDDDDERENFEITDWDLQNEFNPNRQRHWQTKEEATYGVWAERDSD 
60 
D.m.   1 ---------------MSDNDYERFEITDYDLDNEFNINRPRGRQSRHQQIYGIWADDSEE 
45 
C.e.   1 --------------MEDDDGRESFEINDMDLEYAMNPGGRRRFQNKDQATYGVFAPDSDD 
46 
S.c.   1 -----------------------------MEDSDSNTDKKFFFKKRRIDSYNYSDEEDNN 
31 
                                            * .     :.:    *.     ..:  
                                                      
D.r.   61 DERPSFGGKR-------AKDYSTPVSFVSAGLRKTAAEEKAEREGSDDS-------DAEE 
106 
H.s.   61 DERPSFGGKR-------ARDYSAPVNFISAGLKKGAAEEAELEDSDDEE-------KPVK 
106 
D.m.   46 ESGGEGGTKRRGRAARKPKDYTMPVNFVAGGIQQAGKKKKKALQADDEKGSQKEGAEADQ 
105 
C.e.   47 DDDEQGTSRG---PYKKRSKISAPMSFVSGGIQQGNKIDKDDPASLNLN-------LGGE 
96 
S.c.   32 SSMNS------------DMTYTNDALKTSSGNAPTISKLTK------------------- 
60 
          ..  .                :      :.*                               
                                                      
D.r.   107 APPPPRAAAPKKLQTGGSFKTSQR-FAGGIR-------------------TGQDLGNWEK 
146 
H.s.   107 QDDFPKDFGPRKLKTGGNFKPSQKGFAGGTK-------------------SFMDFGSWER 
147 
D.m.   106 GEESDDSAASGRPAFGQNDPGSSNSSSEEERPTLSRKQPSTTFQHRSHIASERNVGAWEQ 
165 
C.e.    97 KKPKEDDEGSIQIDFDKRTKKAPKQNGAQVFAGMRSSANHG-------AADINQFGSWMR 
149 
S.c.       ------------------------------------------------------------  
                                                                                    
                                                      
D.r.   147 HTRGIG--QKLLQKMGYVPGKGLGKNAQGIVNPIEAKLRKGKGAVGAYGSERTQQS---L 
201 
H.s.   148 HTKGIG--QKLLQKMGYVPGRGLGKNAQGIINPIEAKQRKGKGAVGAYGSERTTQS---M 
202 
D.m.   166 HTRGIG--AKLLLQMGYEPGKGLGKDLQGISHPVQAHVRKGRGAIGAYGPETAASIGGKT 
223 
C.e.   150 GDGNSNKIMKMMQAMGYKPGEGLGAQGQGIVEPVQAQLRKGRGAVGAYGKESTATGPKFG 
209 
S.c.    61 -TYGIG--AKLLSSMGYVAGKGLGKDGSGITTPIETQSRPMHNAGLGMFSNTNSSNYHSE 
117 
              . .   *::  *** .*.*** : .**  *:::: *  :.*  .   :           
                                                      
D.r.   202 QDFPVVDSEEEEEEEFQKELGQWRKEPGT-------AKKKPKYSYRTVDDLKAHGTRANM 
254 
H.s.   203 QDFPVVDSEEEAEEEFQKELSQWRKDPSG-------SKKKPKYSYKTVEELKAKG-RISK 
254 
D.m.   224 NKSIKVDEDVREAKEFKDQLNKWRKGSAGGAE--PMERQGKRYYYKSVEEVIAKGHTSGH 
281 
C.e.   210 ESAADAQKRMAQEGTSSRPTNDDQEKSGLKIKGSWKKSQTVKTKYRTIEDVMEEGMSASR 
269 
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S.c.   118 NEDYLSSEDEVVEGIEQVKFNKTSTEVLG-------EALLNDSGDMTIVRTLRELRLAGV 
170 
           :.    ..        .   ..                        ::     .    .   
                                                      
D.r.   255 SMSRPA-GELAQVKVIDMTGREQKVYNSYSHMSQKHSVP------EEAPLSVSTREQKSS 
307 
H.s.   255 KLTAPQ-KELSQVKVIDMTGREQKVYYSYSQISHKHNVPDDGLPLQSQQLPQSGKEAKAP 
313 
D.m.   282 LLSEKLSKKLGNVRVIDMTGPEKRVLSGYHALGQAKITPEETLYDTEATEKGS---APAC 
338 
C.e.   270 PASHQQSQQYSNIKVIDMTGKQQKIYSGYDSFSMKTRSEYDTVDDEERT----------- 
318 
S.c.   171 QLPESILKELDPLNAVPKPKKDVVVEILQELLGIEKSLEAIRQR------------TSPL 
218 
             .     :   :..:  .  :  :      :.                             
                                                      
D.r.   308 GFALPELEHNLKLLIELTEQDILQSARLLQHEKDTVVTLTHESDALQVRLAEEEETLGRL 
367 
H.s.   314 GFALPELEHNLQLLIDLTEQEIIQNDRQLQYERDMVVNLFHELEKMTEVLDHEERVISNL 
373 
D.m.   339 VFAMPELTHNLQLLVSQCEQQIIAIDNQERECSSQQAALESEHRKLEEIVQLERNHIRTL 
398 
C.e.   319 VFDVPELIHNLNLLVDLTEEGIRRSNQQLISLKDQTTALEYDLQQVQKSLGTEEQEAQHI 
378 
S.c.   219 EVQVKEYYGQERLLSELEVTLRDESKHVSLYDKIGAILKLSDDELIDRLTSCLLRKELLI 
278 
            . : *   : .** .          .              :   :        .    :  
 
                                                      
D.r.   368 EQVMSLVERFEAGDKEGDP-ALSLQECAKIFEQLQTEFYQEYKTMGLGDLAVSVVHPLLK 
426 
H.s.   374 SKVLEMVEECERRMQPDCSNPLTLDECARIFETLQDKYYEEYRMSDRVDLAVAIVYPLMK 
433 
D.m.   399 EESLERVERLIDNPD------LSLPQAERLFRELLVDYAAEFHEFGLADLAAGVIAPLLK 
452 
C.e.   379 KDVYELIDGFSSNRSP------SMEECQELFRRLRSEFPHEYELYSLETVAIPTVLPLIQ 
432 
S.c.   279 EFDLDHLEKPNDILD------------ELTQIIELLAYRMDTTSKFLNRTQTTIFKVIYP 
326 
           .   . ::      .                      :  :             .  :    
                                                      
 
 
D.r.   427 EKLRNWDPLKDCSDGLEEVGQWRAILESTL------SLHSGPDTTNMDPYHRLIWEVWVP 
480 
H.s.   434 EYFKEWDPLKDCTYGTEIISKWKSLLENDQ------LLSHGGQDLSADAFHRLIWEVWMP 
487 
D.m.   453 RELVQWQPLENPTEPLPLIKKWRGMLQQGD------AAEQQPR-NVFDPYSSLIWAGVMP 
505 
C.e.   433 KYFVAWKPLEDKNYGCELISTWRDILDDSKNGRKMTFGHNKTKGDEIRAYDRIIWEGILP 
492 
S.c.   327 KLKKFWEGFDMTKSKIDSAITLLLDFQQVLS--------------FIGCKEHIMEEFVYP 
372 
           .    *. :.  .            ::.                        ::     *  
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D.r.   481 VMRTCVSQWQP-RNVGPMVD--CVECWAPVLPLWILDHVLEQLIFPRLQREVDNWNPLTD 
537 
H.s.   488 FVRNIVTQWQP-RNCDPMVD--FLDSWVHIIPVWILDNILDQLIFPKLQKEVENWNPLTD 
544 
D.m.   506 SFRSSAAAWQP-KEHPPMAS--LLDAWAPLLPSWVLDSVLEQLVLPRLVAGVQEWDPLTD 
562 
C.e.   493 SIRRACLQWDPSTQMHEMIE--LVEQWIPLLSAWITENILEQLVVPKIAERVNQWDPMTD 
550 
S.c.   373 KLLQELDNWELHDEVDHVSPRIWVLDFMVLIDDKIKDTIVDKIEAKFFAYCKNWYHRESF 
432 
            .      *:   :   :     :  :  ::   : : :::::    :    : :.  :   
                                                      
D.r.   538 TVPIHSWIHPWLPLMQTRLEP-LYAPIRSKLAHALQRWHPSDSSARLILQPWRDVFTPGA 
596 
H.s.   545 TVPIHSWIHPWLPLMQARLEP-LYSPIRSKLSSALQKWHPSDSSAKLILQPWKDVFTPGS 
603 
D.m.   563 TVPIDSWVLPWHAILGSKLEEAVYPQIRSKLGIALRAWSPHDRSARAMLTPWQKAFPEEE 
622 
C.e.   551 EIPIHEWLVPWLVLLGDRIQT-VMPPIRQKLSKALKLWDPMDRSALETLRPWQNVWSAAT 
609 
S.c.   433 CITNSDIIFIKELICERRYYKILCKEFLPKFLDELWERHNDPIYELEDWKEKQEWKEKDS 
492 
            :.  . :     :   :    :   :  *:   *                 :.        
                                                      
D.r.   597 WEAFMVKNIVPKLALCLGELVVNP-HQQLLDPFNWVMDWECMLSVSSMVGLLDKNFFPKW 
655 
H.s.   604 WEAFMVKNIVPKLGMCLGELVINP-HQQHMDAFYWVIDWEGMISVSSLVGLLEKHFFPKW 
662 
D.m.   623 MQEFLQRYIVPKLQATLGELIIIP-MHQDLELWQQVWEWHELIDPMYMAQLLDRHFFPRW 
681 
C.e.   610 FSAFIAQNIVPKLGVALDTMELNPTMNPEYPEWTACMEWLEFTHPDAIANIVTKYFFPRF 
669 
S.c.   493 GFFYFMKKLRSYTHYFHPKQYELMMRGTFNNINKILYQWHLYS---TVEDLHKSKWWLNW 
549 
              :: : : .                          :*        :  :    :: .:  
                       
D.r.   656 LQVLCSWLSN-NPNYEEITKWYLGWKGLLSENLLSHPLVKEKLNEALDIMNRAVASGLGG 
714 
H.s.   663 LQVLCSWLSN-SPNYEEITKWYLGWKSMFSDQVLAHPSVKDKFNEALDIMNRAVSSNVGA 
721 
D.m.   682 MQVLVVWLNQ-SPDYAEISRWYTGWKSMLSEPLLREPSVKEHLRRALEIMHRASDTLLQP 
740 
C.e.   670 YNCLCLWLDSPGVDYNEVKRWYGSWKARIPQVLVNYPTVNENLRRSMIAIGRSLQGEKVG 
729 
S.c.   550 LMNTVFEHSLPTEIELSEIRKSYNIFAMSHRYHLDKSTLDEDFDLRQGLRNLMETQVIDD 
609  
                   .                    .  :   .  .      :  . :.:.:                 
                                                      
D.r.   715 YMQPGARENIAYLIQTERRKDFQCELQPERREVDNSATRPPGMAAVPASVPTNFKDLVQA 
774 
H.s.   722 YMQPGARENIAYLTHTERRKDFQYEAMQERREAENMAQR--GIGVAASSVPMNFKDLIET 
779 
D.m.   741 TVTPTPPP-------------------------PVPPAPVIMMDLIHPPAQLEFKELVSQ 
775 
C.e.   730 GLQATPIAPMAP-----------------------PPPMAPHFTQAAPVQKLSLKEIIEY 
766 
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S.c.   610 ISQSEQEP--------------------------TYTVQNIPLGKVSSSFKDVVEDYCLE 
643 
              .                                .     :    .     .::      
 
 
                                                      
D.r.   775 KAEENGIVFMPLVAKRHMGKQLFTFGRIVIYIERGVVFVQGE--KTWVPTSLQSLIDMAK 
832 
H.s.   780 KAEEHNIVFMPVIGKRHEGKQLYTFGRIVIYIDRGVVFVQGE--KTWVPTSLQSLIDMAK 
837 
D.m.   776 QCADLGIIFAPLPGRREMGKQIYRVGKLFCYIDRHVCMVSDGSFSNWKPVSLNHLLERSQ 
835 
C.e.   767 TAGKNGFTYHPQKDRYKDGRQVFWFGALSIYLDSEMVYVMDPIEFVWRPSGLNELIQMAQ 
826 
S.c.   644 KGYLISKIPNRYTQLPYGRDQDCIVPLFEIRNGKKKMEVALKHDILWVEDSSGTFKPIYL 
703 
                .              *   .  :          *       *   .   :       
                                                      
D.r.       -----  
H.s.       -----  
D.m.   836 TGIL- 839 
C.e.   827 GAQG- 830 
S.c.   704 WALDL 708 
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C-terminus (spp382-7 or spp382-8) show wild type growth whereas a nearby 
frameshift mutation results in slowed growth (spp382-6). A GAL1 driven N 
terminal deletion (spp382-4) that shifts the translational start to codon 34, 
supports efficient cell growth on galactose based medium (Fig 3.3 B and 3.3 C). 
I noted that the spp382-1 mutant grows less well when expressed from 
this plasmid than when expressed from its normal chromosomal locus. I 
speculated that this might be due to a too-short 3’UTR in the plasmid construct. 
To test this, I re-created the construct with a longer 3’ UTR (original clone was 
2527 base pairs (bp) ending at the stop codon while the 3’ UTR clone is 2677 bp 
with additional 150 bp downstream of the stop codon) and this strain grows as 
well as the chromosomal integrant (Fig 3.3 C). This observation suggests that the 
too-short 3’ UTR exacerbates the spp382-1 growth defect and may contribute to 
the weaker growth of the other spp382 mutants. However it should be noted that 
the short 3’UTR by itself is not particularly inhibitory, since the spp382-7 and 
spp382-8 clones grow as well as wild type. 
Next the newly created spp382 mutants were tested for the ability to 
suppress the prp38-1 defect. The plasmid based spp382 mutants were 
transformed into a prp38-1 strain with a chromosomal deletion of the SPP382 
locus (i.e., spp382::KAN) and a URA3-linked wild type allele of SPP382. The 
spp382 mutant alleles were checked for suppression by growing the strain at    
37 °C after removal of the URA3-linked SPP382 by plasmid shuffle. Suppressor 
alleles were found distributed throughout the coding sequence (i.e., spp382-1,  
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FIG. 3.3 Spp382p is essential for cell viability. A. PCR-based mutagenesis 
was targeted to conserved regions of Spp382p (based on UniProtKB entries: 
Q06411, Q9UBB9, Q6DI35, Q9NHN7, and Q17784). Panel A shows the amino 
acid changes and numbered coordinates on the 708 amino acid protein. B. 
Growth assays performed in yeast with the indicated spp382 allele at 23 °C and 
at 37 °C. C. Growth assay showing the effect of shortened 3’ UTR. The growth of 
a plasmid borne spp382-1 with the short 3’ UTR (spp382::KAN, p-spp382-1), a 
plasmid borne spp382-1 with elongated 3’UTR (spp382::KAN, p-spp382-1 + 
3’UTR), and that of a chromosomal spp382-1 strains at 23 °C and 37 C 
compared to wild type and prp38-1 mutant. It should be noted that the figure B 
and C are a composite of multiple plate cultures incubated at the indicated 
temperatures for identical periods of time. 
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Table 3.1 Suppression by titration of an essential splicing activity. Visible 
colonies from an otherwise inviable prp38-1mutant were indicative of 
suppression (Yes) while no growth indicates no suppression (No). NA means not 
applicable. * indicates that this allele was expressed with the GAL1 promoter, all 
other alleles were expressed with the SPP382 promoter. ** indicates the strain is 
lethal. 
 
Allele prp38-1  suppression 
SPP382 NA 
prp38-1 NA 
spp382-1 Yes 
spp382-2 No 
spp382-3 No 
spp382-4* Yes 
spp382-5 Synthetic Lethal 
spp382-6 Yes 
spp382-7 No 
spp382-8 Yes 
spp382-9** NA 
spp382-10** NA 
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spp382 -4, spp382 -6 and spp382-8). The tightly ts allele, spp382-5, is lethal in 
the prp38-1 background. None of the mutations were found to suppress a lethal  
prp38::KAN null allele and similarly the prp38-1 mutation does not rescue the 
lethality of the spp382-9 or spp382-10 mutations (Table 3.1). 
Spp382p is required for splicing and for normal intron metabolism. 
Incomplete repression of transcription prevented the use of 
GAL1::SPP382 to assess the cellular role of Spp382p in splicing (Fig 3.4A). But 
the metabolic depletion can be achieved using the functional GAL1::spp382-4 
allele which shows time dependant inhibition of splicing and growth (Fig 3.4 B 
and data not shown). Under this condition, no change is observed in the 
intronless ADE3 transcript or the mature rRNA (Fig 3.4 B). 
 The level of splicing inhibition observed with the spp382 point mutants 
was shown to parallel the growth impairment (Fig 3.5). Mutants with strong 
growth defects (spp382-1, spp382-2, spp382-3, spp382-5, and spp382-6) show 
significant splicing inhibition, especially at higher (37 °C) temperature. Mutants 
that support robust growth show little splicing inhibition (e.g., spp382-7, spp382-
8).  
Mutations in some splicing factor genes, especially those splicing factors 
involved in spliceosome disassembly, accumulate excess levels of excised intron 
(Arenas and Abelson 1997); (Martin, Schneider et al. 2002). It is believed that the 
residual bound splicing factors inhibit the turnover pathway. I decided to probe 
whether excess intron accumulates in the spp382 mutants by probing my  
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FIG 3.4. Spp382p is required for splicing. Northern analysis of splicing 
inhibition with yeast that express the nutritionally regulated GAL1::SPP382 
(Panel A) or GAL1::spp382-4 gene (Panel B) (T=0) and 4 to 20 hours after 
transcriptional repression by glucose. Yeast that express the wild type allele 
(SPP382) and were assayed in parallel after growth in galactose (T=0) or 
glucose (T-=20). The positions of the intronless ADE3 mRNA and the RPS17A 
pre-mRNA and mRNA and the mature rRNA are shown to the left.  
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northern blot with the ACT1 intron (Fig 3.5, lower panel). For unknown reasons, 
ACT1 is more sensitive in this assay than RPS17A. I quantified the intron 
accumulation using ImageQuant software. The intron accumulation is greatest 
with the central domain mutants, spp382-1(9 fold more at 37 C) and spp382-5 
(15 times more than control at RT and 23 fold more at 37 °C) and with one of the 
G-patch mutants, spp382-3 (9 times increased at RT) when compared with the 
wild type. spp382-6 only accumulates about 2 times more intron, when compared 
with the control. There seems to be no simple correlation between intron 
accumulation and suppression. For instance, while spp382-1 accumulates 
excess intron and suppresses prp38-1, spp382-3 and spp382-5 accumulate 
much more excised intron but do not suppress prp38-1. spp382-6 and spp382-8 
suppress prp38-1 but accumulate little excess intron. While excess intron 
accumulation presumably relates to splicing impairment, I note that even this is 
not a simple relationship. For instance, for spp382-3 intron accumulation is more 
evident at 23 °C when there is little or no splicing impairment. However, at 37 °C 
where splicing inhibition is seen, intron accumulation is not observed.  
Presumably, the spp382-1 suppressed prp38-1 strain grows better 
because splicing efficiency is improved. To address this, I compared splicing in 
the suppressed strain to the wild type and the mutant prp38-1 parent. Although 
the mRNA to pre-mRNA ratio (an established measure of splicing efficiency 
(Rymond, Pikielny et al. 1990) reproducibly increases, the enhancement in 
splicing is very subtle when assayed with either RPS17A or RPL28. Based on 
this, it seems that neither ribosomal protein is likely limiting for growth under the  
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FIG 3.5. Spp382p is required for normal intron metabolism. Northern analysis 
done with wild type yeast, the prp38-1 mutant, and the non-lethal spp382 
mutants assayed at room temperature (-) or after 2 hours at 37 °C (+). The lower 
panel shows accumulation of the ACT1 excised intron RNA.  
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Intron accumulation in 25 °C 37 °C 
WT * 1X 1X 
Prp38-1 1X 1X 
Spp382-1 3X 9X 
Spp382-2 1X 1X 
Spp382-3 9X 1X 
Spp382-5 15X 15X 
Spp382-6 2X 2X 
Spp382-7 1X 1X 
Spp382-8 1X 1X 
 
* The intron accumulation is compared to that seen occurring normally in wild 
type (default (1X)) 
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 FIG 3.6. Splicing efficiency of the spp382-1, prp38-1 strain. Splicing of the 
prp38-1 mutant and the prp38-1, spp382-1 double mutant at 23 °C and after 2 
hours at 37 °C (+). The 25S and 18S rRNA bands are presented as 
normalization controls for RNA loading and transfer. 
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conditions of assay (Fig 3.6), although it is possible that modest decreases to 
many ribosomal protein genes combine to impair growth. 
To find out at which step splicing is blocked after Spp382p inactivation, I 
performed primer extension analysis. RNA was extracted from strains 
transformed with a well established reporter gene, HZ18, that contains the intron 
and flanking exon sequences of the ribosomal protein, RP51A (renamed 
RPS17A) fused to lacZ (Teem and Rosbash 1983). Primer extensions were 
carried out using an oligonucleotide complementary to exon 2, RB1 (Rymond, 
Pikielny et al. 1990). The primer extension products generated by RB1 include 
pre-mRNA, lariat intermediate and spliced message (the heterogeneous mRNA 
population is because of multiple start sites of the CYC1 promoter). The primer 
extension analysis shows accumulation of pre-mRNA rather than the lariat 
intermediate in the mutant spp382-1 background, even at room temperature (Fig 
3.7). Similar results were obtained for spp382-6 (Fig. 3-7 and for spp382-
2,spp382- 3 and spp382-5 (data not shown). Thus, while reported dispensable 
for splicing in vitro (Chan, Kao et al. 2003), Spp382p is essential for first 
transesterification step in vivo. 
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FIG 3.7. Spp382 mutants inhibit the first step of splicing. Primer extension 
analysis of RNA isolated from spp382 mutants and a wild type strain using an 
exon 2 oligonucleotide complimentary to a RPS17A reporter. The position of 
cDNA molecules corresponding to unspliced fusion transcripts (HZ18), spliced 
fusion message, lariat intermediate and spliced endogenous message is 
indicated to the right.  
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Extracts from yeast depleted of Spp382p fail to assembly complete 
spliceosomes.  
Spp382p might function directly in splicing or act indirectly, for instance, by 
stabilizing poorly spliced pre-mRNAs. To investigate the impact of Spp382p 
depletion on the splicing apparatus, splicing complexes assembled in vitro on 
biotin-substituted RPS17A pre-mRNA were affinity-purified by streptavidin-
agarose chromatography and assayed for snRNA content. As seen in Figure 3.8, 
with the wild type extract, the earliest complexes recovered contain U1 and U2 
snRNAs and some U4, U5 and U6 snRNAs. As the assembly progresses, the 
relative yields of U5 and U6 snRNAs increase. The expected release of U4 
snRNA (Xie, Beickman et al. 1998) from the spliceosome can be seen as a time 
dependant decrease in the recovered U4 snRNA relative to the U6 snRNA 
(compare lanes 9,12). Note that non-specific association of unmodified (i.e., 
biotin-free) pre-mRNA or snRNAs with the streptavidin agarose matrix is 
insignificant (lanes 6 and 13). Metabolic depletion of the essential Rcp10 protein, 
a protein we recently identified as an essential U2 snRNP SF3b component 
(Wang, He et al. 2005), blocks assembly after U1 snRNP addition showing 
spliceosome assembly arrest at the commitment complex stage (lane 7). 
Metabolicl depletion of Spp382p (see Material and Methods) allows the U2 
snRNP to be added (i.e., prespliceosome formation) but assembly arrests at that 
point. Note that the total snRNA levels remain comparable to wild type (lane 1 
and 8) and hence snRNAs are not degraded in the absence of Spp382p. This 
indicates that, in extracts from cells depleted of Spp382p, impaired U4/U6.U5 tri- 
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FIG 3.8. Removal of Spp382p blocks splicing complex assembly at the 
prespliceosome stage. Splicing complexes assembled on biotin substituted 
RPS17A pre-mRNA for the indicated times were affinity purified by streptavidin 
agarose chromatography and assayed for snRNA content (arrow heads) by 
northern blot. Total = Total, unselected extract RNA; no biotin = parallel reaction 
conducted with pre-mRNA lacking biotin. 
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snRNP addition limits spliceosome assembly. This block might result from 
reduced U4/U6.U5 snRNP assembly or from reduced U4/U6.U5 snRNP affinity 
for the prespliceosome. In either case, genetic depletion of Spp382p reproducibly 
results in splicing-inactive extracts that fail to assemble splicing complexes 
beyond the prespliceosome stage.  
 
Spp382p is not an integral snRNP protein but its depletion inhibits stable 
tri-snRNP formation in vivo.  
To investigate whether Spp382p is associated with the major spliceosomal 
snRNP particles, I first looked for evidence of co-sedimentation in a 15-45% 
glycerol gradient. I checked alternate fractions of the yeast Spp382-TAP extract 
(an epitope-tagged derivative) for the presence of Spp382-TAP and the splicing 
associated snRNPs. I note that the SPP382-TAP is expressed from its native 
promoter at its original genetic locus and therefore is likely present at normal 
levels. 15 µl of extract from the alternate fractions were run on an SDS protein 
gel and probed with an antibody that binds to the TAP epitope. At the same time, 
RNA isolated from alternate fractions was resolved on denaturing polyacrylamide 
gel and hybridized with snRNA-specific probes to see the distribution of snRNPs 
across the gradient. Most of the Spp382-TAP was found in fractions 3-9 that 
include the bulk of cellular proteins (mostly fractions 1-7), well separated from the 
majority of the snRNP complexes. I note that the Spp382-TAP profile does 
overlap the free U6 snRNP and the U4/U6 di-snRNP (Fig 3.9, Panel A and Panel 
B). While not shown here, the large U1 and U2 snRNP  
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FIG 3.9. Spp382p's relationship to the tri-snRNP. A. Extract from cells 
expressing Spp382-TAP was fractionated on a 15 to 40% glycerol gradient and 
odd numbered samples assayed by western blot an anti -TAP antibody (lanes 1-
23). The lanes marked "Total" show un-fractionated extract.  
B. Northern analysis of snRNAs present in the glycerol gradient fractions.  
C. Northern analysis of snRNAs recovered by immune precipitation with Spp382-
TAP, untagged extract, and the U5-specific Aar2-TAP. 
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particles broadly resolve over the deeper half of the gradient (see Fig. 3.9, 
below). Based on this, I conclude that under these low stringency salt conditions 
(150mM NaCl concentration) much of the Spp382p likely exists independent of 
the major snRNP complex forms driving spliceosome assembly (i.e., U1, U2, 
U4/U6.U5 snRNPs).  
To further investigate whether Spp382p associates with the spliceosomal 
snRNPs, I next tested whether the U1, U2, U4, U5, or U6 snRNAs co-purify with 
Spp382-TAP affinity purified on IgG agarose. Northern blot analysis of the 
recovered RNA (Fig. 3.9 C) shows that Spp382 precipitates mostly the U5 
snRNA. While typically 35-50% of the cellular Spp382p could be recovered, no 
more than 10% (and generally less) of the U5 snRNA was recovered, indicating 
that Spp382p is unlikely to be a core U5 snRNP protein. This is consistent with 
previous reports on the yeast U5 snRNP composition (Stevens, Barta et al. 
2001). Aar2-TAP, a component of the U5 snRNP and the gene representing the 
second suppressor identified in my screen (see below), also precipitates U5 
snRNA. as well as U1 snRNA as shown previously reported by Fabrizio and 
Luhrmann (Gottschalk, Kastner et al. 2001). Background binding to the protein A 
resin is negligible under these conditions (No Tag lane).  
I next wanted to address whether Spp382p depletion alters the snRNP 
composition of a cell. Extracts prepared from yeast with a normal Spp382p 
content and from a strain metabolically depleted for Spp382p (by glucose 
repression of GAL1-spp382-4) were resolved by glycerol gradient fractionation 
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and then assayed by northern blot as described above (Fig 3.10) Unfractionated 
RNA present in the extract is marked as “Total”.  
With wild type extract, the free U6 snRNP migrates in the top of the 
gradient (fractions 3-5, panel A), followed by the U4/U6 di-snRNP complex (lane 
7-11, A). The U5 snRNP fractionates across the gradient whereas the tri-snRNP 
is found near the bottom of the gradient (fractions17-21, A). The final fraction 
contains, in addition to tri-snRNP particles, endogenous spliceosomes and 
insoluble aggregates. In contrast to the wild type extract, there is little tri-snRNP 
present after Spp382p depletion (lane 17-21, B) and the relative amount of 
U4/U6 complex increases (compare fractions 7-11 in A and B). The asterisk 
indicates the position of what is likely free U5 snRNP although the co-
fractionation of significant amounts of (especially) U6 and U2 may indicate that 
this is a more complex mixture. Note that the total snRNA levels are comparable 
in the two extracts (Total, A and B) and hence failure to observe much stable tri-
snRNP is not a consequence of snRNA instability. The increase in U4/U6 snRNA 
levels along with decreased tri-snRNP suggests a defect in the assembly or 
recycling of snRNP particles for instance, the U2/U5/U6 post splicing complex 
which might be represented in lane 13. 
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FIG 3.10. Depletion of Spp382p inhibits stable tri-snRNP formation. Cell 
extracts of a wild type strain (panel A) or GAL1::spp382-4 strain (panel B) grown 
on glucose (to effect metabolic depletion of Spp382p) were layered onto a 15-
45% glycerol gradient and the snRNP complexes resolved by centrifugation. 
RNA was isolated from odd numbered fractions and assayed by northern blot for 
snRNP composition using snRNA specific probes (lanes 1-23 in panel A and B). 
Lanes marked "Total" refers to un-fractionated RNA present in the extract. The * 
in Panel B represents the position of what may be the free U5 snRNP or an 
aberrant from of the spliceosome (U2, U5, U6). 
 73 
 
 
 
 
 
 
 
 
 74 
 
 
 I also monitored snRNP assembly by running native polyacrylamide 
gels with extracts that contain Spp382p or are depleted of the protein (see 
Material and Methods for details). After transfer, the blot was hybridized with 
radiolabeled snRNA-specific probes. Consistent with the glycerol gradient 
fractionation results, when Spp382p is depleted in vivo, tri-snRNP assembly is 
affected. With U5 snRNA specific probe, the Spp382p depleted lane shows little 
or no tri-snRNP, compared with the non depleted or wild type control (Fig 3.11, 
Panel A). When probed with either U5 or U6 snRNA specific probe, an aberrant 
complex (see * in the Figure 3.10, migrates more slowly compared to tri snRNP) 
is seen (Fig 3.10, Panel B). I also detected U2 in this complex when I probed the 
blot with a U2 specific probe (data not shown). This appears to be a stalled late 
spliceosome, with the U2.U5.U6 snRNAs. Taken together this indicates that 
depletion of Spp382p negatively affects tri-snRNP assembly or stability. 
 
Spp382p binds spliceosomes including defective complexes that lack the 
5’ exon. 
To investigate whether Spp382p associates with the splicing complex, I 
affinity purified a Tap-tagged derivative (Spp382-TAP) by IgG-agarose selection 
from in vitro assembled splicing complexes and assayed for co-recovery of the 
uniformly labeled substrate. As controls, extracts were also assayed from cells 
that express Prp19-TAP, a protein that stably binds the spliceosome right before  
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FIG 3.11. SnRNP profile of Spp382p depleted extracts. Splicing extracts were 
prepared from wild type cells or from GAL1::spp382-4 strain grown on glucose 
(to effect metabolic depletion of Spp382p). The extracts were analyzed by native 
gel electrophoresis and northern blotting. The position of the tri-snRNP 
(U4/U6.U5), disnRNP(U4/U6) and free U6 are indicated. The * denotes a slowly 
migrating complex enriched after Spp382p depletion that might represent an 
aberrant spliceosome.  
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or concurrently with U4 loss, and BBP-TAP, a protein that associates transiently 
with the spliceosome early in assembly. 
The Prp19-TAP protein pulls down the lariat intermediate and excised 
intron and free 5’ exon in similar relative amounts compared with the input 
sample (Fig. 3.12, panel A, lanes 13-18). A little unprocessed pre-mRNA is also 
recovered but no spliced mRNA is found associated with the Prp19-TAP, 
consistent with the very rapid dissociation of mRNA from the spliceosome. Only a 
minor amount of pre-mRNA, but no lariat intermediate or excised intron is 
recovered with a TAP tagged branchpoint binding protein (BBP). As expected 
with a protein that binds early and transiently to the splicing apparatus, the pre-
mRNA signals decrease to background (WT no tag) with BBP-TAP, late in the 
splicing reaction (Fig. 3.12, panel A, lanes 7-12).  
Both lariat intermediate and excised intron are recovered with Tap-tagged 
Spp382p (Fig. 3.12, panel A, lanes 1-6). When compared to the input RNA, the 
recovery of excised intron appears favored, especially late in the splicing 
reaction. Some unprocessed pre-mRNA but  little or no spliced mRNA is found in 
the bound fraction. Unlike Prp19-TAP, little or no 5’ exon signal is detected in the 
Spp382-TAP IgG pellet, even with a four-fold increase in exposure time (Fig. 
3.12, panel A, compare lanes 4-6 and 28-30). The absence of the 5’ exon is 
unexpected since this is not a natural form of the splicing complex. 
To further investigate the binding of Spp382p to “5’ exonless” complexes, I 
assayed a substrate truncated just upstream of the 3’ splice site (Fig. 3. 12, panel 
B) for which the lariat intermediate and free exon accumulate as terminal 
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products (since no downstream exon exists). Nonspecific RNA binding to the 
resin is negligible (lanes 11-12) and, as before, lariat intermediate and 5’ exon 
are recovered from the 30 minute splicing reaction with Prp19-TAP in amounts 
that approximate the 2.5:1 signal ratio expected based on nucleotide content 
(lanes 9, 10). With Spp382p, lariat intermediate is recovered as is some pre-
mRNA, but, as before, little or no free 5’ exon is found in the IgG pellet (lanes 1 
and 2).  
The trivial possibility that Spp382-TAP IgG selection causes release of the 
upstream exon appears unlikely as free (i.e., non-spliceosomal) 5’ exon is 
resolved by glycerol gradient fractionation prior to selection (Figure 3.13 A). In 
addition, lariat intermediate molecules are preferentially recovered from lighter, 
possibly incomplete spliceosomal fractions (Fig 3.13, panels A and B). I note, 
however, that when complexes are first fractionated by glycerol gradient 
sedimentation more 5’ exon is recovered with Spp382-TAP. The reason for this is 
unknown. 
 Less pre-mRNA is recovered with Spp382-TAP or with BBP-TAP than 
with Prp19-TAP (Fig. 3.12 B, compare lanes 2, 4, 10 with lane 12). Although the 
amount of pre-mRNA recovered with the TAP tagged proteins is low, it appears 
to be specific. For instance, the recovery is enhanced (and splicing blocked) in 
extracts where the BBP-TAP commitment complex is stabilized by 
oligonucleotide-directed RNase H digestion of U2 snRNA (compare lanes 4 and 
6 in Fig 3.12 B, in the lower exposure detail). No change is observed if a control 
oligonucleotide is used (Fig 3.12 B lane 8). For Spp382-TAP, the pre-mRNA 
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recovered comes exclusively from the spliceosomal 40-50S fractions even 
though most of the pre-mRNA remains in the unassembled pool (Fig 3.13 panel 
A and B) again consistent with recovery from splicing complexes.  
These results suggest that Spp382p may bind weakly or transiently to a 
subset of spliceosomal complexes, including complexes that have lost the 5’ 
exon. To investigate the role of the upstream exon in sample recovery, I repeated 
the splicing reactions with RPS17A substrates where the 38 nucleotide 5’ exon 
was lengthened (+13) or shortened by 16 or 25 nucleotides (Fig. 3.12 C). As 
measured by phosphorimaging, the lariat intermediate to fully excised intron (L/I) 
ratio, a measure of step two splicing inhibition, increases ~1.2-fold between the 
shortest and longest substrates (lanes 1–4). In contrast, this ratio more than 
doubles in the Spp382-TAP-recovered pool (lanes 5–8). This greater than 
proportionate increase reinforces the belief that a distinct subset of lariat 
intermediates, specifically the defective complexes, are being selected by 
Spp382-TAP. I note that based on the yield of RNA found in the IgG pellet, such 
complexes represent a very small percentage of lariat intermediate, less than 5% 
of the lariat intermediate present in the splicing reaction. 
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FIG 3.12. Spp382p binds defective spliceosomes. A. In vitro pre-mRNA 
splicing with 32P-labeled RPS17A pre-mRNA processed for the indicated times 
under standard conditions (Pikielny, Rymond et al. 1986) and assayed by 
denaturing PAGE before (Total) or after IgG agarose selection (IgG). The detail 
(det.) to the right shows a 4-fold overexposure of the first 6 lanes to highlight the 
absence of upstream exon with IgG-agarose selected Spp382-TAP. The 
positions of the unprocessed pre-mRNA (P), lariat intermediate (LI), excised 
intron (I), spliced mRNA (M) and free upstream exon (5’E) are indicated.  
B. In vitro splicing and RNA recovery with a 3’ splice site truncated RPS17A 
mRNA blocked for the second step of splicing. Alternating lanes show the total 
processed RNA (T) and the IgG agarose pellets (P) after 30 minutes of splicing. 
The asterisk shows the position of linearized lariat intermediate sometimes 
observed under these conditions. The detail below (det.) shows a 4 fold 
underexposure of the corresponding pre-mRNA region to highlight the enhanced 
substrate recovery by IgG agarose after U2 snRNA degradation.  
C. Extended (+13) or shortened ( 16, 25) 5' exon RPS17A substrates were 
spliced for 30 min under standard conditions and then assayed for products 
before (lanes 1–4) or after (lanes 5–8) Spp382-TAP selection. The 5' exons 
(below the bar) were run on a second gel to resolve the smaller fragments.  
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FIG 3.13. Exon release occurs before Spp382-TAP selection in lighter 
spliceosomal complexes. After 30 min of splicing with the 3’ splice site 
truncated RPS17A mRNA in the Spp382-TAP extract, complexes were resolved 
by velocity sedimentation in a 15-40% glycerol gradient. A. Alternate fractions 
were assayed on a denaturing polyacrylamide gel and the positions of the 
splicing precursor and intermediates are noted on the left. 
B. The indicated gradient fractions were pooled, selected by IgG agarose, and 
resolved by denaturing PAGE as total, unselected RNA (T), or RNA enriched in 
the IgG agarose pellet (P).
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Genetic interactions of Spp382p.  
Chen et. al showed that Prp43p requires Spp382p for intron release from 
the spliceosome in vitro (Chan, Kao et al. 2003). This observation raises the 
interesting possibility that the suppression of prp38-1 by mutants of spp382 
results from impaired spliceosome dissociation by Prp43p. If this is true, then the 
prp38-1 stalled spliceosome must retain partial residual activity since 
suppression of a fully inactive complex would not be possible by this mechanism. 
Also one predicts that spp382-based suppression would not be restricted to 
prp38-1 but would extend to other defects in the spliceosome assembly pathway. 
Consistent with the first prediction, I find that overexpressing prp38-1p (the 
mutant protein) also suppresses the prp38-1 strain similar to the previously 
characterized dosage suppressor, SPP381 (Fig 3.14, 37 °C panel). This confirms 
that the prp38-1p spliceosomes have residual activity.  
To test the second prediction, I scored additional conditional mutations 
within the components of the splicing enzyme for suppression. Like prp38-1, 
prp38-2, another mutant allele of PRP38 (Xie, Beickman et al. 1998), is also 
suppressed by spp382-4 (data not shown).  I also tested spp382 mutants’ ability 
to suppress various other splicing mutants. I choose mutants which blocked the 
spliceosome at distinct steps in assembly, catalysis and disassembly. I find that 
the ts prp8-1 mutant (blocked before activation) is suppressed by spp382-4 (Fig 
3.14) and also by the spp382-1 and spp382-6 alleles. Spp382-6 also suppresses 
prp19-1, a single point mutant of Prp19p, which binds the spliceosome after or at 
the same time U4 snRNA leaves (Chan and Cheng 2005). No suppression is 
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observed with splicing mutants, prp4-1 (spliceosomes in mutants blocked prior to 
catalysis)(Fig 3.15), prp3-1 (mutants locked at pre-spliceosome stage), prp6-
1(mutants blocked at pre-spliceosome stage), rds3-1(mutants blocked prior to U2 
snRNP binding), (Wang and Rymond 2003) prp39-1(U1 snRNP binding fails in 
mutants), (Lockhart and Rymond 1994) when tested with either spp382-4 and 
spp382-6. Likewise, no suppression was observed with mutant derivatives of two 
DExD/H-box proteins encoded by prp16-1 (mutants blocked at step 1) and 
prp22-1 (mutants fail to release message). Finally, in support of a functional 
association of Spp382p and Prp43p, I find that the prp43R424A mutation (Martin, 
Schneider et al. 2002) is synthetically lethal with the spp382-4 and spp382-6 
(data not shown).  
I also initiated an investigation into spp382 mutants’ ability to suppress 
weak substrate mutations. I transformed spp382-1 and spp382-6 with reporter 
plasmids (Rymond, Pikielny et al. 1990) which contain a RPS17A intron with 
either a wild type branchpoint ( HZ18, UACUAAC), a strong branchpoint mutation 
(UACUAAC  UACUACC, HZ10) or a weak branchpoint mutant (UACUAAC  
UCCUAAC, HZ3). The transformants were patched on dropout (minimal) plates 
lacking uracil and the level of beta-galactosidase activity was checked by overlay 
assay (see Materials and Methods). As seen in Figure 3.15, both spp382-1 and 
spp382-6 suppress the weak branchpoint mutation as seen with increased beta 
galactosidase activity (compare color intensity in HZ3 panel). No suppression is 
seen with the stronger branchpoint mutation (HZ10) and neither do the mutants 
appear to alter the use of the wild type substrate (HZ18). 
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FIG 3.14. Genetic characterization of extragenic suppression. Yeast with ts 
prp38-1, prp8-1 or prp4-1 mutations were transformed with a plasmid to 
overexpress the mutant prp38-1 allele (GAL1::prp38-1) or the previously 
characterized SPP381 dosage suppressor (GAL1::SPP381). The GAL1::spp382-
4 suppressor was expressed in the prp38-1, SPP382::KanR background. The 
cultures were serially diluted and plated on yeast extract/peptone/galactose 
medium at the restrictive temperature for prp8-1 (30°C) and prp38-1 (37°C). To 
detect even minor changes in growth, a semi-permissive temperature of 30°C 
was used for prp4-1. 
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FIG.3.15. spp382 alleles suppress weak substrate mutants. Wild type or 
spp382 mutant strains were transformed with the indicated RPS17a reporter 
plasmid, grown on selective media for 3 days and then level of beta-
galactosidase activity was checked by overlay assay. 
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Lowered Prp43p ATPase activity suppresses prp38-1 defect. 
To investigate whether spp382 suppression is likely mediated via 
decreased Prp43p activity, I directly tested mutant prp43 alleles for suppression 
of the prp38-1 mutant. I obtained point mutants in the Prp43p DEAD/H box motif 
or in the SAT box motif from the Schwer lab (Martin, Schneider et al. 2002). 
These mutants differ in the level of residual ATPase activity. Among the three 
mutants tested, the DEAD/H box mutant (prp43-H218A) has the lowest ATPase 
activity (27%), while the SAT mutants (prp43-S247A and prp43-T249A) have 
65% and 83% activity when compared to the wild type Prp43p activity (100%).  
Each prp43 mutant was tested for suppression of the prp38-1 growth 
defect at 36C. The double mutants were serially diluted and plated on YPD 
plates at 36C. I found that each prp43 mutant suppressed the prp38-1 defect and 
the degree of suppression was inversely proportional to the reported ATPase 
activity (Fig 3.16). The mutant with the lowest ATPase activity (prp43-H218A) 
suppresses better than the prp43-S247A mutant which in turn is more effective 
than the weakest mutant, prp43-T249A. 
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FIG 3.16. prp43 mutants also suppress prp38-1 defect. Three mutant alleles 
of PRP43 assayed for growth at 36°C in the prp38-1 or wild-type (PRP38) 
background. The Prp43p ATPase activities are from Martin et al (2002). 
It should be noted that the figure is a composite of multiple plate cultures 
incubated at the indicated temperatures for identical periods of time. 
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A point mutant of Aar2p also suppresses the prp38-1 defect. 
In order to identify the other strong recessive suppressor allele, I 
transformed the suppressor strain (E4) with 133 genes (Listed in Table 1 in 
Materials and Methods) that represent most of the known splicing factors as well 
as other genes involved in RNA processing or function. Transformants were 
selected by complementation of a plasmid-linked nutritional marker (URA3) at the 
permissive temperature (23 °C) and then screened by streaking representative 
colonies on nutrient rich media at 37 °C. One candidate gene (AAR2) was 
recovered that blocked E4 suppression (Figure 3.18, lower panel). To confirm 
that this was indeed a plasmid-linked event, the GAL1::AAR2 plasmid was re-
transformed into a naïve E4 suppressed strain. All the secondary transformants 
assayed showed the reacquisition of the temperature sensitive phenotype, 
demonstrating a plasmid-dependent event. Loss of plasmid by counter selection 
through growth in the presence of the anti-metabolite, 5-fluroorotic acid, resulted 
in colonies which were no longer ts (data not shown). Thus, Aar2p was most 
likely to be the suppressor allele. Sequencing of the mutant aar2 locus revealed 
a single nucleotide change (G A) that results in a single amino acid residue, 
D281N. Based on this, I conclude that Aar2p is the other suppressor allele. 
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FIG 3.17. aar2-D281N , a recessive point mutant, suppresses prp38-1. 
Growth of wild-type yeast (PRP38 and AAR2), the prp38-1 mutant, and the 
suppressed prp38-1, aar2-D281N double mutant assayed after 2 days at 37°C in 
YPD. Overexpression of Aar2p inhibits growth of the double mutant (prp38-1, 
aar2D281N) as shown in the lower panel. Both strains were assayed at 37 C on 
YP-Gal after 2 days. 
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Physical interactions of Spp382p with a DnaJ-motif protein, Cwc23p.  
Spp382p has been reported in multiple complex particles recovered 
from yeast cells such as the penta-snRNP (Stevens, Ryan et al. 2002), the U4, 
U5, U6 snRNP spliceosomal complex (Wang, Hobbs et al. 2003) and other 
complexes generally including Prp43p (Gavin, Bosche et al. 2002; Tsai, Fu et al. 
2005). However, since each of these purifications was done at low salt 
concentration, typically 100-150 mM NaCl, the complexity of the recovered multi-
subunit particles prevents assessment of likely primary binding partners of 
Spp282p. To investigate high-affinity primary associations, I purified Spp382p-
TAP at greater stringency (i.e. 450mM NaCl) and assayed for interacting proteins 
by mass spectroscopy. Cwc23p, a Dna J-like protein present in the spliceosome, 
is the only splicing related protein recovered with high confidence in this 
Spp382p-TAP complex (Table 3.2). The two ribosomal proteins and Rep2p (2 
micron circle associated protein) were also identified and likely represent 
contaminants of this preparation.  
The mass spectroscopy results suggest interaction between Cwc23p 
and Spp382p. To address this possibility by an independent methodology, I 
assayed full-length copies of Spp382p and Cwc23p for two-hybrid interactions. 
The yeast tester strain was grown for 3 days at 30 °C on plates lacking histidine 
and supplemented with 20 mM 3-aminotriazole to score for activation of the 
GAL4-regulated HIS3 gene. As seen in Figure 3.18, Spp382p and Cwc23p show 
reciprocal positive interactions in this assay while neither binding partner auto- 
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Table 3.2. Spp382-Cwc23 interaction. List of proteins co-purified with Spp382-
TAP identified by mass spectroscopy.  
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FIG. 3.18. Physical interaction of Spp382p with the spliceosomal DnaJ-like 
protein, Cwc23p. Serial dilutions of yeast stain PJ69-4a transformed with the 
indicated plasmids spotted on plates lacking histidine and supplemented with 3 
aminotriazole and grown at 30 °C for 3 days. 
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stimulates the yeast reporter gene when paired with an empty vector control. The 
two-hybrid results reinforce the interpretation of my proteomic data that the 
Spp38p splicing factor interacts with the uncharacterized Cwc23p spliceosome-
associated protein. 
Cwc23p was previously reported in splicing complexes purified with 
Cef1p (Ohi, Link et al. 2002) and co-purifies with the Prp43p-DExD/H-box 
ATPase (Gavin, Bosche et al. 2002) that acts with Spp382p to stimulate intron 
release from the spliceosome in vitro. Chen and co-workers did not detect 
Cwc23p associated with the Spp382p-Prp43p complex when assayed in vitro by 
western blotting (Tsai, Fu et al. 2005).  
At the time of my observation, no direct evidence existed to show that 
Cwc23p actually plays an active role in the pre-mRNA splicing. In order to 
investigate the cellular function of Cwc23p, I mutated conserved residues within 
Cwc23p based on sequence alignment of the human, zebra fish, mouse, and 
E.coli homologs (Figure 3.19) In addition to these selected sites, I also randomly 
mutated the CWC23 open reading frame using the Genemorph Kit from 
Stratagene. The plasmid-borne CWC23 gene was mutated and then transformed 
into a yeast strain where the essential chromosomal copy of CWC23 was 
replaced with the KANR gene (Winzeler, Shoemaker et al. 1999) and a URA3-
linked wild type CWC23 allele was present on a second plasmid. The activity of 
the mutant allele was determined after removal of the URA3-linked wild type 
copy by FOA selection. Yeast that failed to grow on FOA medium were 
considered to have an inactivating mutation in the targeted CWC23 allele. Yeast 
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viable after FOA selection were considered to possess only the putative mutant 
copy of cwc23 and were scored for growth defects at 19 °C, 25 °C, 30 °C, and  
37°C. All mutant alleles were sequenced to confirm the existence of DNA 
changes.  
The DNA J domain is an 80 amino acid motif (residues 15-95 in 
Cwc23p) (Sahi and Craig 2007). Several of the mutants presented here reside 
within this sequence (cwc23- 1, -2 and -4) or in the case with the more complex 
mutants, at least one of the altered nucleotide lies within this domain (cwc23-
3,5,6,7and 8). Mutations within the highly conserved HPD sub region of the 
Cwc23p J-domain motif were found to impair growth (alleles cwc23-1 and cwc23-
2) (Figure 3.19, residues 50-52 marked in yellow and Figure 3.20). Mutant 
cwc23-3 showed wild type growth at 37 °C but was cold sensitive and grew much 
less well at 30 °C or below (See Figure 3.20 and Table 3.2). A mutant in which 
amino acids 80-84 are deleted (cwc23-4) and cwc23-6 (H65L, L136P, K147P) 
were somewhat less severe but likewise showed growth defects at both the low 
and high temperature. The cwc23-5 mutant with 3 amino acid substitutions 
(L22F, L136P, K147R) grows slowly at all temperatures. Mutants cwc23-7 and 
cwc23-8 were lethal. For all the complex changes (cwc23-3, 5, 6, 7, 8), it is 
unclear whether it is changes in the J-domain or the mutations outside the J-
domain or a combination of mutations in both result in the growth impairment or 
lethality.
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FIG 3.19. Alignment of the Cwc23p homologs across species. The 
abbreviations used are, E.c – Escherichia coli (UniProt accession number 
P08622), D.r – Danio rerio (UniProt accession number Q7ZUW0), H.s – Homo 
sapiens (UniProt accession number Q96EY1), M.m- Mus musculis (UniProt 
accession number Q99M87), S.c - Sacchromyces cereviciae(UniProt accession 
number P52868). 
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M.m.   1 ---MAAWCSPRWLRVAVGTPRLPAAAGRGVQQPQGGVVATSLCRKLCVSAFGLSMGAHGP 
57 
H.s.   1 ---MAARCSTRWLLVVVGTPRLPAISGRGARPPREGVVGAWLSRKLSVPAFASSLTSCGP 
57 
D.r.   1 MACSAARSSARWISAAVSSSHSRACSPFIPRADGAYRGFKSLSGRQMWTTRGGLSGGAGA 
60 
E.c.     ------------------------------------------------------------  
S.c.     ------------------------------------------------------------  
                                                
                                                     
M.m.   58 RALLTLRPGVRLTGTKSFPFVCTTSFHTSASLAKDDYYQILGVPRNASQKDIKKAYYQLA 
117 
H.s.   58 RALLTLRPGVSLTGTKHYPFICTASFHTSAPLAKEDYYQILGVPRNASQKEIKKAYYQLA 
117 
D.r.   61 AVTLSG-----MTAIGSSHVVCKMSFHTSAPSRKQDFYQILGVPRSATQKEIKKAYYQMA 
115 
E.c.    1 -------------------------------MAKQDYYEILGVSKTAEEREIRKAYKRLA 
29 
S.c.    1 --------------MPGHELEDVINQRLNLYDVLELPTPLDVHTIYDDLPQIKRKYRTLA 
46 
                                                 :   .      :*:: *  :*  
                                                     
M.m.  118 KKYHPDTNKDDPKAKEKFSQLAEAYEVLSDEVKRKQYDAYGSAGFDPGTSSS-GQGYWRG 
176 
H.s.  118 KKYHPDTNKDDPKAKEKFSQLAEAYEVLSDEVKRKQYDAYGSAGFDPGASGS-QHSYWKG 
176 
D.r.  116 KKYHPDTNKEDPQAKEKFAQLAEAYEVLSDEVKRKQYDTYGSAGFDAGRAGAGHQQYWGG 
175 
E.c.   30 MKYHPDRNQGDKEAEAKFKEIKEAYEVLTDSQKRAAYDQYGHAAFEQGGMGG-----GGF 
84 
S.c.   47 LKYHPDKHPDNPSIIHKFHLLSTATNILTNADVRPHYDRWLIEFLRKTNDIE-------- 
98 
           : *** :  : .   **  :  * : *::   *  ** :                      
                                                     
M.m.  177 GPSVDPEELFRKIFGEFSSSP-FGDFQNVFDQPQEYIMELTFNQAAKGVNKEFTVNIMDT 
235 
H.s.  177 GPTVDPEELFRKIFGEFSSSS-FGDFQTVFDQPQEYFMELTFNQAAKGVNKEFTVNIMDT 
235 
D.r.  176 GTSIDPEELFRKIFGEFSGAQGFGDFNAIFNQPQEYVMELTFAQAAKGVNKEITVNIEGT 
235 
E.c.   85 GGGADFSDIFGDVFGDIFGGG-RGRQRAARGADLRYNMELTLEEAVRGVTKEIRIPTLEE 
143 
S.c.   99 ----RNKLIQKLEESESSTIPTTTPHPDLLQIQRHGELLRKLKHFNLPYGDWKHLNTQD- 
153 
                        ..                         :                    
                                                     
M.m.  236 CERCDGKGNEPGTKVQHCHYCGGSGMETINTGPFVMRSTCRRCGGRGSIITNPCVVCRGA 
295 
H.s.  236 CERCNGKGNEPGTKVQHCHYCGGSGMETINTGPFVMRSTCRRCGGRGSIIISPCVVCRGA 
295 
D.r.  236 CQRCDGRGHEPGSKVQHCGNCNGTGMETVNTGPFVMRSTCRRCGGRGSVITSPCIACRGT 
295 
E.c.  144 CDVCHGSGAKPGTQPQTCPTCHGSGQVQMRQGFFAVQQTCPHCQGRGTLIKDPCNKCHGH 
203 
S.c.  154 ---------QENASQHPYYDCSTLRIVLDNFLQSNNKSNCLSHLR--------------- 
189 
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M.m.  296 GQAKQKKRVTIPVPAGVEDGQTVRMP---------VGKREIFVTFRVQKSPVFRRDGADI 
346 
H.s.  296 GQAKQKKRVMIPVPAGVEDGQTVRMP---------VGKREIFITFRVQKSPVFRRDGADI 
346 
D.r.  296 GQTKQRKTVTVPVPAGIEDGQTVRMP---------VGKKEIFITFKVQKSPIFRRDGADI 
346 
E.c.  204 GRVERSKTLSVKIPAGVDTGDRIRLAGEGEAGEHGAPAGDLYVQVQVKQHPIFEREGNNL 
263 
S.c.  190 --------------------------------------NQVFITLSANEIYDIYFSERNN 
211 
                                                 .: . .       :     :   
                                                     
M.m.  347 HSDLFISIAQAILGGTAKAQGLYETIN-VTIPAGIQTDQKIRLTGKGIPRINS-YGYGDH 
404 
H.s.  347 HSDLFISIAQALLGGTARAQGLYETIN-VTIPPGTQTDQKIRMGGKGIPRINS-YGYGDH 
404 
D.r.  347 HSDVMISVAQAILGGTIRAQGLYETIN-LSIPVGTQTDQRIRLSGKGIPRVSG-YGYGDH 
404 
E.c.  264 YCEVPINFAMAALGGEIEVPTLDGRVK-LKVPGETQTGKLFRMRGKGVKSVRG-GAQGDL 
321 
S.c.  212 YSKDDSIIIYTVFDTPITAQHVFRNWS----------------SGNLIPTVKDISPLIPL 
255 
            .    .  :  .       :                      *: :              
                                                     
M.m.  405 YIHIKIRVPKRLSSRQQNLILSYAEDETDVEGTVNGVTHTSTGGRTMDSS--AGSKDRRE 
462 
H.s.  405 YIHIKIRVPKRLTSRQQSLILSYAEDETDVEGTVNGVTLTSSGGSTMDSS--AGSKARRE 
462 
D.r.  405 YVHIKIKIPKMLTDRQRALMMSYAEDESDVEGTVNGVTSTTAGKRSAGN----------- 
453 
E.c.  322 LCRVVVETPVGLNERQKQLLQELQESFGGPTGEHNSPRSKSFFDG--------------- 
366 
S.c.  256 HYYSDFNLETELNDDIARLVSNEPILLD-------------------------------- 
283 
               .               .                                        
M.m.  463 AGEDNEGFLSKLKKIFTS 480 
H.s.  463 AGEDEEGFLSKLKKMFTS 480 
D.r.      ------------------  
E.c.  367 ----VKKFFDDLTR---- 376 
S.c.      ------------------  
 106 
 
 
FIG.3.20. Growth characteristics of cwc23 mutants. A. PCR-based 
mutagenesis of CWC23. The panel shows the amino acid changes and 
numbered coordinates on the 395 amino acid Cwc23 protein. B. Serial dilutions 
of cwc23 mutants along with wild type yeast grown on YPD for 4 days at 25 °C 
and 2 days at 37 °C. It should be noted that the figure B is a composite of 
multiple plate cultures incubated at the indicated temperatures for identical 
periods of time. 
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Table 3.3. Growth phenotypes of cwc23 mutants.  
The yeast cells were grown for 7 days at 19 °C, 4 days at 25 °C, 3 days at 30 °C 
and 2 days at 37 °C.  
 
Growth Phenotype @ Name Change 
19 °C 25 
°C 
30 
°C 
37 
°C 
Cwc23-1 HPD 50,51,52 AAA +/- +/- + + 
Cwc23-2 H50A +/- +/- + + 
Cwc23-3 H50G, D52A, R209G, 
S240G,K247R 
+/- + ++ +++
Cwc23-4 H82, Y83, D84 deleted + +/- + + + 
Cwc23-5 L22F, L136P, K147R +/- +/- +/- +/- 
Cwc23-6 H65L, L136P, K147P, E155X ++ ++ ++ ++ 
Cwc23-7 V79A,L136P, K137X Lethal 
Cwc23-8 L22F, L136P, K147R, I204V, S239I Lethal 
CWC23  NA +++ 
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Cwc23p is essential for normal cellular splicing. 
 Similar to what was shown above for GAL1::SPP382, incomplete 
metabolic depletion prevents the use of regulated GAL1:: CWC23 to access the 
role of the protein in cellular splicing (i.e., this strain continues to grow on 
glucose-based medium; data not shown). Consequently, to investigate Cwc23p 
function in pre-mRNA splicing, I conducted northern analysis using RNA 
harvested from cells bearing the newly generated mutant alleles. To maximize 
the chances of seeing an effect, I used conditions designed to stress the cells at 
temperatures above or below the optimal growth temperature (of wild type yeast) 
at 30 °C. Specifically, I assayed yeast after temperature shift from 30 °C to 19 °C 
for 10 hours and after shift to 37 °C for 2 hours.  
 Splicing is impaired for both the J domain mutants (cwc23-1 and 2) 
and for cwc23- 3 and cwc23-4 as the RPS17A pre-mRNA/mRNA ratio increases 
relative to wild type yeast (Figure 3.21). I note that splicing is impaired for these 
mutants even at temperatures where growth inhibition is not clearly seen. The 
cwc23-5 mutant was clearly splicing impaired at 36 while no splicing defects 
were obvious with cwc23-6 mutant. Minor differences in the levels of excised 
actin intron were also observed although, in general, the elevated ACT1 intron 
levels were more modest that what was observed with the spp382 mutants. 
Primer extension analysis was performed to investigate whether pre-
mRNA or the similarly sized lariat intermediate accumulated after Cwc23p 
inactivation (Figure 3.22). Reverse transcription extension with an end-labeled 
RPS17A exon II oligonucleotide demonstrates primarily a step 1 block for  
 110 
 
 
FIG. 3.21. Cwc23p is essential for efficient cellular splicing. Northern 
analysis of the non-lethal cwc23 alleles along with the wild type yeast and the 
prp38-1 mutant assayed at 19 C (-) or after 2 hours at 37 °C (+). The lower panel 
shows accumulation of the ACT1 excised intron RNA.  
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FIG 3.22. cwc23 mutants show inhibition of the first transesterification 
reaction in splicing. Primer extension analysis of RNA isolated from the 
indicated cwc23 mutants and a wild type strain. Reverse transcription was 
conducted with oligonucleotide complimentary to exon 2 of the RPS17a reporter. 
The position of cDNA molecules corresponding to unspliced transcripts (pre-
mRNA ), spliced message (mRNA), lariat intermediate (lariat) and spliced 
endogenous RPS17a message (asterisk) is indicated to the right. 
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alleles tested (i.e., cwc23-1,-2, -3, and -4) indicating that the protein plays a role 
in the first RNA cleavage ligation event in splicing. I cannot rule out a second role 
later in splicing for the Cwc23p, however, since a strong block at the first 
transesterification reaction would mask later defects in splicing. 
Genetic interactions of CWC23 
I note that Cwc23p is the only J-domain protein reported to date in 
the spliceosome. The 80 amino acid J-domain motif was first defined in the E. 
coli DnaJ protein, a Hsp40-like protein in which the J domain plays a role in 
substrate presentation and or ATPase activation of an associated chaperone 
(e.g., Hsp70) (Qiu, Shao et al. 2006). DNA J motif proteins are involved in the 
assembly and disassembly events associated with a diverse set of multi-subunit 
complexes (Walsh, Bursac et al. 2004). In this light, the previously stated 
Spp382p- Cwc23p- Prp43p association is particularly intriguing as this defines 
possible associations with DExD/H-box recruitment factor (Spp382p), an enzyme 
(Prp43p) and possible regulator (Cwc23p). To explore this possibility, I 
overexpressed CWC23 using the GAL1 promoter in wild type yeast and in prp43 
mutant yeast with decreased Prp43p ATPase activity.  
 The prp43 mutants transformed with a negative control plasmid 
(GAL1::CYC1) grow like the wild type strain on both glucose and galactose at 30 
°C (figure 3.23). Overexpression of CWC23 does not impair growth of a wild type 
strain either on glucose or galactose. While overexpression in the mutant, prp43-
H218A (27 % ATPase activity; (Martin, Schneider et al. 2002)), impairs cell 
growth when grown on YP-galactose plates. This growth inhibition is reversed  
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FIG. 3.23. Overexpression of Cwc23p exacerbates the growth of prp43 
ATPase mutants. Prp43 mutants were transformed with a plasmid to over 
express Cwc23p (GAL1::CWC23). The cultures were serially diluted and 
separately plated on either YP-Gal or YP-Dextrose medium at the permissive 
temperature for prp43 mutants (30°C).  
It should be noted that the figure is a composite of multiple plate cultures 
incubated at the indicated temperatures for identical periods of time. 
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when the cells are grown on glucose. Overexpression of Cwc23p in the other 
prp43 mutant, prp43- T249A (83 % ATPase activity; (Martin, Schneider et al. 
2002), does not have any apparent effect on growth (Figure 3.23). This 
observation indicates that excess Cwc23p impairs cell growth when Prp43p 
ATPase activity is significantly reduced. 
I showed above, within a certain range, reduced Spp382p activity or 
reduced Prp43p activity suppresses prp38-1 and prp8 splicing mutants (Figure 
3.14 and 3.16). I also scored all the cwc23 mutants for possible suppression of 
the prp38-1 and prp8-2 associated growth defects. (Figure 3.24 A and C). None 
of the cwc23 mutants suppress the prp38-1 growth inhibition at 36C or the prp8-1 
or the prp8-2 temperature sensitivity at 30 °C. However, I do observe that prp8-2 
suppresses the growth defect of the J domain cwc23 mutants at lower 
temperatures (cwc23-1 and 2). While both cwc23-1 and cwc23-2 mutants grow 
poorly at 19 °C, both strains grow better at this temperature when combined with 
prp8-2. This suppression can be reversed when a wild type PRP8 is introduced 
into the strain (Fig 3.24 B) indicating that improved growth of the cwc23 mutants 
is due to the prp8 mutation. Thus, while providing genetic evidence for Cwc23p 
interaction with the conserved Prp8p protein that believed part of the 
spliceosome’s active site (Grainger and Beggs 2005), this experiment did not 
reveal a suppressor phenotype for any of the cwc23 alleles generated so far.  
 Simultaneous transformation of the Cwc23p and Spp382p as Gal4 fusion 
products lead to strong transactivation of the HIS3 in the yeast two hybrid 
reporter strain, PJ694a. I tested whether the cwc23 mutants showed impaired  
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FIG. 3.24. Genetic Interactions of Cwc23p. A. Serial dilutions of the double 
mutants along with the parents were spotted on yeast extract/peptone/dextrose 
medium and grown for 7 days in 19 °C or 3 days at 30 °C. B. Serial dilution of the 
double mutants along with or without the wild type PRP8 grown on YPD at 19 °C 
for 10 days. C. Serial dilutions of the cwc23, prp38-1double mutants along with 
the parents spotted on YPD and grown for 3 days in 30 °C or for 2 days at 37 °C. 
It should be noted that the figures are a composite of multiple plate cultures 
incubated at the indicated temperatures for identical periods of time. 
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 FIG. 3.25. Two hybrid interactions of cwc23-1 and cwc23-2 with Spp382p. 
The yeast strain, PJ69-4a, bearing the indicated plasmids indicated below, was 
streaked on plates lacking histidine and supplemented with 3 aminotriazole and 
grown at 30 °C for 3 days.  
Panel A 
1. pACT::Cwc23p + pAS2 –Spp382p 
2. pACT::Cwc23p  
3. pAS2 –Spp382p 
4. pACT-cwc23-1p + pAS2 –Spp382p 
5. pACT::cwc23-1p  
6. Empty 
Panel B  
7. pACT::Cwc23p + pAS2 –Spp382p 
8. pACT::Cwc23p  
9. pAS2 –Spp382p 
10. pACT-cwc23-2p + pAS2 –Spp382p 
11. pACT::cwc23-2p  
12. Empty 
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interaction with Spp382p. I tested Spp382p two hybrid interaction with cwc23-1p 
and cwc23-2p. For either mutant fused to the GAL4 activation domain (the pACT 
constructs, Figure 3.25 panel A -4 and B-10), I fail to see any colonies, indicating 
loss of interaction.  
 
Overexpression of multiple different splicing factors inhibits 
growth of the spp382-1, prp38-1 double mutant suppressor 
strain. 
I proposed that Spp382p mediates suppression due to impaired 
dissociation of the spliceosome via Prp43p. Based on this model, any change 
that enhances spliceosome turnover might be expected to counteract spp382-1-
based suppression. To identify possible effectors of spliceosome turnover, the 
GAL1 promoter was used to overexpress 133 yeast genes (See Materials and 
Methods), including most known splicing factors, in yeast in the original 
“suppressor” strain (that is, bearing both the prp38-1 and spp382-1 mutations) on 
rich medium containing galactose as sugar source, at 37 °C. While most genes 
did not influence growth, PRP43, SPP382, CWC23, and orf YNL224c (that I call 
SQS1 for squelch of splicing suppression) were among 14 genes found to impair 
growth relative to the empty vector control transformant (Figure 3.26 A). The 
remaining GAL1 effectors encode a variety of splicing factors (Bud13p, Bud31p, 
Prp8p, Prp9p, Prp11p, Prp39p, Yhc1p), a protein involved in mRNA export and 
turnover, Dhh1p, and, surprisingly, mitochondrial ribosomal proteins Yml6p and 
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Mrp13p. The effect of overexpression on suppression was also checked at 
permissive conditions for prp38-1 (i.e., 23 °C). Only MRP13 and SQS1 
significantly impair growth of the suppressor strain at 23 °C on YP-galactose 
(Figure 3.26 B). 
 The GAL1 promoter is transcriptionally induced 100 to 1000 fold by 
galactose. To learn if the growth defects observed required such high levels of 
induction, the transformants were assayed for growth on rich glucose-based 
media at 23 C and 37 °C. None of the effector genes altered growth relative to 
the control strain on YPD at 23 °C (data not shown). GAL1 repression on glucose 
causes the GAL1::PRP9 and GAL1::MRP13 transformants to reacquire the 
suppressed (i.e., better growth) phenotype (Fig. 3.26 A) at 37 C. This is not true 
for most transformants, however, indicating that even a modest increase in 
effector protein level reduces spp382-1 efficacy as a suppressor. Unexpectedly, 
the GAL1::PRP43 and GAL1::BUD13 transformants appear more effective in this 
assay when yeast are cultured on glucose. That is, the strains grow less well on 
glucose-based medium than on the galactose-based medium. 
To investigate whether the impaired growth observed with 
overexpression required the double mutant (i.e., prp38-1, spp382-1) background 
I checked the growth of the single mutant parental strains and in wild type yeast. 
Other than the exceptions noted below, none of these genes significantly alter 
growth of the spp382-1 or prp38-1 single mutants when assayed on rich medium 
(Figure 3.26B). Overexpression of Prp43p-associated protein Ntr2p (Tsai, Fu et 
al. 2005) relieves the modest ts defect of the spp382-1 single mutant (Figure 
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3.27B). As expected, overexpression of PRP38 and SPP381 enhance growth of 
the prp38-1 single mutant (Figure 3.27 B) with minor impact on the (prp38-1, 
spp382-1) suppressor strain (Figure 3.26 B). SPP381 does not suppress the 
prp38-1 defect when assayed on glucose medium, indicating that significantly 
increased protein levels are needed to suppress this mutant strain ((Blanton, 
Srinivasan et al. 1992; Xie, Beickman et al. 1998). None of these genes affect 
the growth of wild type strain when assayed on rich medium.  
YNL224C/SQS1 overexpression was reported to impair cell cycle 
progression (Stevenson, Kennedy et al. 2001). Yet, we see no obvious growth 
defect when this gene is expressed in wild type yeast on YP-galactose medium. 
To investigate this obvious discrepancy, we reassayed growth of the 
transformants on selective minimal media (lacking uracil and with galactose or 
glucose as sugar source), the conditions used by the earlier group. 
Overexpression of all constructs except SPP381 or PRP38 impairs growth of the 
double mutant at 37. In addition, for PRP8, BUD31, MRP13, YML6, YHC1, 
PRP39 and SPP382, the growth inhibition is reversed when grown on the drop-
out glucose medium (Figure 3.26 C). Overexpression of SQS1, DHH1, PRP8, 
PRP43, BUD13, BUD31, YML6 and SPP382 also inhibit growth of the double 
mutant at 23 °C in galactose while none of the constructs show impaired grown 
on glucose at 23 °C.  
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FIG 3.26. Impact of overexpression under different conditions. A. Double 
mutant (prp38-1, spp382-1) yeast cultures transformed with the indicated GAL1 
fusion genes were serially diluted and spotted at 37 °C on medium to induce 
(galactose) or repress (glucose) the GAL1 promoter.  
B. The prp38-1, spp382-1 double mutant, wild type yeast (WT), the spp382-1 
single mutant, and the prp38-1 single mutant strain transformed with either the 
control (GAL1::CYC1) or the indicated GAL1 driven plasmids and assayed for 
growth at permissive temperature (23 C or 35C) or restrictive temperatures in 
YPGal or glucose based medium. The cultures were grown in parallel in the 
same experiment as Fig A. The far end of permissive temperature (35C) was 
selected for prp38-1 to increase the chance of observing minor exacerbations of 
temperature sensitivity.  
C. The prp38-1, spp382-1 double mutant and wild type yeast (WT), transformed 
with either the GAL1::CYC1or the GAL1 driven constructs and assayed for 
growth at permissive temperature (23 C) or restrictive temperatures in media 
lacking uracil, with either galactose or glucose as the sole source for sugar. The 
cultures were grown in parallel in the same experiment as Fig A. 
It should be noted that the figures are a composite of multiple plate cultures 
incubated at the indicated temperatures for identical periods of time. 
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  Unlike the case for rich medium, overexpression of SQS1, BUD31, DHH1, 
and MRP13 also inhibits growth of the wild type yeast strain at 30°C and 37°C 
when cultured on the defined medium. Overexpression of PRP8, CWC23, YML6 
and SPP382 impairs growth of the wild type at 37°C. The growth inhibition in 
these genetic backgrounds is reversed in all cases when the transformants are 
grown in selective glucose medium. Based on this, I conclude that 
overexpression of some splicing factors hypersensitizes the spp382 mediated 
suppression and in some cases impairs growth of otherwise wild type yeast. 
Finally, for all the constructs, I confirmed that transformants revert to the original 
growth state after plasmid removal (data not shown). 
 
Over expression of Sqs1p impairs cellular pre-mRNA splicing. 
As noted above, overexpression of Sqs1p can impair growth of even 
the wild type yeast. In addition, I note that like Spp382p, Sqs1p is a G-patch 
protein (see figure 3.27) The increased sensitivity of the suppressed strain 
(prp38-1, spp382-1) to Sqs1s overexpression and the fact that Sqs1p can be 
affinity selected with complexes containing the Prp43p-DExD/H-box factor 
(Gavin, Bosche et al. 2002), suggest possible involvement of Sqs1p in splicing. 
To investigate this, I analyzed pre-mRNA splicing in wild type yeast grown in 
drop out glucose media (lacking uracil) and various times after shift to galactose 
(Figure 3.28 A) to induce GAL1::SQS1. While the pre-mRNA- message ratio 
(indicator of splicing efficiency) is similar to control cells when grown in glucose, 
the value increases as the time in galactose increases. Similar results were 
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obtained when Sqs1p overexpression was assayed in the prp38-1 single mutant 
or the suppressed double mutant prp38-1, spp382-1 (data not shown). The 
control which lacks GAL1::SQS1 shows no inhibition of splicing when grown in 
galactose media. Under this condition no change is seen with the intronless 
ADE3 gene. While splicing is inhibited, over expression of Sqs1p does not affect 
the stability of the splicing associated snRNAs. Northern analysis of the snRNAs 
shows that while splicing is impaired, the snRNAs are not degraded (Figure 3.28 
C).  
The SQS1 gene is not essential for yeast viability (SGD database) 
and I observe no growth defect in a sqs1::KAN knockout strain when grown at 
RT or at 37 °C (Figure 3.30). While the overexpression results suggest splicing 
involvement, northern analysis of RNA isolated from a sqs1::KAN null mutant 
shows no obvious defect in splicing under normal (RT) or elevated temperature 
(37 °C) (Figure 3.28 B). Thus, while overexpression of Sqs1p is cytotoxic and 
inhibits splicing, the absence of this protein does not significantly impair pre-
mRNA splicing.  
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FIG. 3.28. G-patch alignment of Spp382p and Sqs1p. Alignment of G-patch 
motif with the consensus below. The sequences are named using the notation 
Protein name _ Species abbreviation_Gene Bank GI (Gene identification 
number). Abbreviations used Sc - Saccharomyces cerevisiae, Hs - Homo 
sapiens, Sp -Schizosacchromyces pombe, Ca -Candida albicans, At - 
Arabidopsis thaliana. 
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FIG.3.28 . Overexpression of Sqs1p impairs splicing. A. Northern analysis of 
splicing inhibition with wild type yeast transformed with the nutritionally regulated 
GAL1::SQS1 gene before and up to 9 hours after transcriptional induction by 
galactose. Yeast that express a negative control vector (GAL1::CYC1) were 
assayed in parallel after growth in glucose (T=0) or galactose (T-=9). The 
positions of the intronless ADE3 mRNA and the RPS17A pre-mRNA and mRNA 
are shown to the right. 
B. Northern analysis of sqs1::KAN, a strain with chromosomal deletion of SQS1 
along with a wild type strain and spp382- grown either at room temperature (-) or 
at 37 °C (+).The positions of the intronless ADE3 mRNA and the RPS17A pre-
mRNA and mRNA are shown to the left 
C. Northern analysis of the RNA from the overexpression experiment described 
above (A) assayed for snRNA stability. The positions of snRNAs are indicated to 
the right. 
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Sqs1p interactions with Spp382p and related factors. 
  Three proteins, Spp382p, Cwc23p and Sqs1p were identified in this 
study as having genetic or biochemical links to Prp43p. I investigated interactions 
with this protein set by a directed two-hybrid study using full length proteins. As 
shown before (Figure 3.18), Spp382p interacts with Cwc23p. Sqs1p was found to 
interact with Spp382p but not with Cwc23p. Intriguingly, I could not generate a 
double transformant of Sqs1p and Prp43p, indicating that simultaneous 
expression of both factors as full length Gal4p fusion proteins is deleterious to 
the cell. Consistent with previously published reports (Tsai, Fu et al. 2005), 
Spp382p was observed to interact with the Prp43p DExD/H-box protein in the 
two hybrid study. No interaction was detected between Cwc23p and Prp43p by 
this assay (Figure 3.29).  
As overexpression of Sqs1p impairs spp382p mediated suppression 
of prp38-1, I tested if absence of SQS1 had any effect on growth of the prp38-1 
mutant. SQS1::KAN neither suppressed nor exacerbated growth of the prp38-1 
mutant (Figure 3.30).  
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FIG 3.29. Two Hybrid interactions of Sqs1 with Spp382p and related factors. 
Serial dilutions of the reporter yeast strain containing the indicated two hybrid 
vectors was spotted on with medium lacking adenine (-Ade, glu) or lacking 
histidine and supplemented with 20mM 3-aminotriazole (-His, glu +20 mM 3AT) 
and grown at 30 °C for 3 days. It should be noted that the figure is a composite of 
multiple plate cultures incubated at the indicated temperatures for identical 
periods of time. 
 
 141 
 
 
 
 142 
 
 
FIG 3.30. Sqs1 null allele does not suppress prp38-1. Serial dilutions of the 
indicated strains were spotted on the YPD plate and incubated at 25 °C for 4 
days and 37 °C for 2 days. 
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CHAPTER 4. 
DISCUSSION 
The spliceosome is a complex, dynamic ribonucleoprotein (RNP) complex 
that undergoes numerous conformational changes during its assembly, 
activation, catalysis and disassembly. Many of these conformational changes are 
stimulated by the eight spliceosomal DExD/H box proteins at the expense of 
ATP. While needed for the spliceosome cycle, surprisingly little is known of how 
spliceosomal DExD/H proteins are recruited, the molecular details of target 
association, what governs the temporal restriction of their enzymatic activities, or 
even the primary targets of ATP-dependent function (e.g., RNA unwinding or 
protein displacement). In contrast, the spliceosome assembly defects associated 
with the loss of each activity is well documented. In their landmark studies on the 
Prp16p DExD/H-box protein, Burgess and Guthrie proposed a model in which the 
fidelity of correct branchpoint selection is coupled to ATP hydrolysis (Couto, 
Tamm et al. 1987; Burgess, Couto et al. 1990; Burgess and Guthrie 1993). More 
recently, Prp22p has been proposed to act in a similar manner during the 3’ 
splice site selection. Both results illustrate what might be considered a basic 
gatekeeper feature of DExD/H-box ATPases in toggling alternative 
conformational states. Here, the ATP hydrolysis by each of the DExD/H proteins 
would drive the spliceosome cycle forward to the subsequent step and assure 
fidelity in splicing when coupled with a discard pathway for the removal of flawed 
complexes (Brow 2002; Query and Konarska 2004; Konarska and Query 2005). 
Key to the underlying “kinetic proofreading” mechanism is the existence of a 
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discard pathway to remove defective complexes. This discard pathway would 
insure against faulty and potentially deleterious splicing events as well as 
promote the recycling of limiting spliceosomal factors. While the components are 
unknown, such a discard pathway has been speculated to act with DExD/H box 
proteins throughout the spliceosome cycle as a quality control system for splicing 
complex integrity (Konarska and Query 2005). 
The underlying hypothesis of my research is that a spliceosomal discard 
pathway exists in yeast and acts with the DExD/H box-proteins to promote 
faithful splicing. My dissertation studies used a genetic approach to identify 
putative components of this pathway and employed genetic, molecular, and 
biochemical methodologies to investigate the contributions of the identified 
factors to pre-mRNA splicing. This project was initiated with a genetic modifier 
screen that isolated trans-acting suppressors of the prp38-1 mutant. Our 
previous studies provided strong evidence that prp38-1 mutant yeast produced 
complete but kinetically impaired spliceosomes (Blanton, Srinivasan et al. 1992; 
Xie, Beickman et al. 1998). I proposed that the prp38-1 suppressors would likely 
fall into two groups, 1) suppressors that improve splicing directly and 2) 
suppressors that disable the discard pathway and thereby give more time for the 
“slow” spliceosomes to work. Both predictions were supported by my 
observations. For the first class, many intragenic suppressors were recovered. 
These were noted but not chosen for further study since our primary interest was 
in extragenic events.  
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I propose that the mutation recovered within the uncharacterized open 
reading frame, YLR424w, is characteristic of the second type of suppressor, 
namely a suppressor that indirectly improves splicing through impairment of the 
discard pathway. I have registered this gene with the Saccharomyces Genome 
Database as SPP382, for the second suppressor of prp38-1 (that is suppressor 
prp38-1 #2). The amino acid sequence of Spp382p provides little insight into its 
function although this is clearly an evolutionarily conserved protein (Figure 3.2 ) 
that associates with components of the yeast and mammalian spliceosomes 
(Gavin, Bosche et al. 2002; Hazbun, Malmstrom et al. 2003; Deckert, Hartmuth 
et al. 2006; Collins, Kemmeren et al. 2007; Wang, Q., K. Hobbs, et al. 2003). 
This protein does contain a G-patch motif, a ~ 48 amino acid motif containing six 
highly conserved glycine residues, implicated in RNA binding. Other G-path 
proteins in yeast include SPP2, PXR1, SQS1 and an unknown open reading 
frame, YLR271w. Spp2p, like Spp382p, has been implicated in recruitment of a 
DExD/H factor, Prp2p. Pxr1p is implicated in rRNA and snoRNA maturation and 
the other two (Sqs1p and Ylr271w-p) are largely uncharacterized. 
We previously observed the YLR424w –encoded protein as Ccf8p in a 
proteomics study of the yeast spliceosome (Wang, Hobbs et al. 2003). This 
earlier work used a late-acting splicing factor, Clf1p, in an affinity selection 
scheme to identify subunits of the mature spliceosome. At least two distinct 
multisubunit complexes were affinity purified with Clf1p, the mature or 
postcatalytic spliceosome containing late-acting splicing factors and the U2, U5 
and U6 snRNAs and the RNA-free Prp19-complex (NTC) that acts late in the 
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assembly pathway and is released from the spliceosome after catalysis (Tsai, 
Chow et al. 1999; Chen, Yu et al. 2002; Wang, Hobbs et al. 2003). Of the ~30 
proteins characterized, Ccf8p was unique in that it was the only factor 
preferentially enriched in the NTC fractions, prompting our suggestion that Ccf8p 
may be an important factor in NTC-spliceosome dynamics (Wang Hobbs etc, 
2003). As discussed below, I believe that the results of my studies and other 
recent observations support this conclusion. 
Though essential for cell survival, nothing was known about the cellular 
role of Spp382p in splicing at the time of my investigation. To begin to address 
this, I mutated conserved residues based on sequence homology. Mutating 
conserved residues in the G-patch either results in cell death (spp382-9 or 10) or 
impairs cell growth (spp382-2 or 3), indicating that this domain is essential for the 
protein’s function. In general, mutations that affect growth also impair splicing 
and accumulate precursor mRNA at restrictive temperature, indicating that this 
protein is essential for the first transesterification reaction in vivo.  
I found that extracts made from cells that were metabolically depleted of 
Spp382p (spp382-4 grown in glucose) block spliceosome assembly prior to the 
addition of the tri–snRNP, i.e. at the pre-spliceosome stage. While this suggests 
a role in stable recruitment of the U4/U6.U5 tri-snRNP particle, we were not able 
to efficiently complement this defect by exogenously added Spp38p, leaving 
open the possibility that the initial Spp382p depletion resulted in the 
destabilization or parallel depletion of other factors acting at this stage in splicing.  
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Some of the mutants (spp382-1, -3, -5 and -6) also accumulate excess 
amounts of the excised intron, as shown when probed with actin probe. 
Accumulation of intronic RNA is seen with mutants that play a role in 
spliceosome disassembly, like the 2’-5’ phosphodiesterase that linearizes the 
lariat intron, Dbr1p, or the DExD/H protein involved in intron release and 
spliceosome disassembly, Prp43p (Chapman and Boeke 1991; Arenas and 
Abelson 1997), suggesting a role for spp382 in disassembly of the splicing 
apparatus. Indeed it is quite possible to interpret the block in spliceosome 
assembly seen with metabolically depleted extracts as indirect and resulting from 
impaired recycling of splicing factors necessary for the first step of splicing. 
Extracts prepared from yeast cells metabolically depleted of Spp382p by 
transcriptional repression of a GAL1 fusion allele also showed little or no tri-
snRNP, increased amounts of the U4/U6 di-snRNP particle and what could be a 
U2. U5.U6 snRNP (see band labeled * in figure 3.10). Based on total RNA pools, 
spliceosomal snRNA stability does not appear to be reduced in cells 
metabolically depleted for Spp382p as it is seen with the inactivation of certain 
other splicing factors (e.g. Blanton et al., 1992). When the snRNP assembly is 
monitored using native gels, the depleted extract shows an aberrant, slowly 
moving complex above the tri-snRNP. A lesser amount of this complex can be 
seen with functional extracts, consistent with the possible super-accumulation of 
snRNP particles in a spliceosome like complex under Spp382p-limiting 
conditions. In brief, my results show that Spp382p depletion in vivo does affect 
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the tri- snRNP assembly, possibly because of impaired disassembly of the 
spliceosome. 
Chen and co-workers showed that Spp382p is necessary in vitro for intron 
release from the mature spliceosome by the DExD/H helicase, Prp43p (Tsai, Fu 
et al. 2005). While the mechanism is not known, Spp382p and Prp43p were 
shown to interact by the two-hybrid method, supporting speculation that Prp43p 
may act as a recruitment factor for Prp43p (Tsai, Fu et al. 2005). While my data 
is consistent with such a model, I believe that other models may also explain 
these results and the other published work. For instance, it is possible that 
Spp382p acts more directly in Prp43p activation or substrate presentation.  
The role of Prp43p in the dissociation of the late-stage spliceosome is 
consistent with a similar activity in the proposed discard pathway. Since, at least 
in vitro, Prp43p activity requires Spp382p, spp382 mediated suppression of 
splicing factor mutations might reflect lowered Prp43p activity. Martin et. al. 
showed that the ATPase activity was necessary for the Prp43p in vivo function 
and a threshold activity of the protein was essential for viability (Martin, 
Schneider et al. 2002). I tested the ability of three such viable prp43 mutants with 
successively lower ATPases activities to suppress prp38-1. In keeping with my 
assumption, I find that the prp43 mutants suppress the prp38-1 defect. 
Importantly, the degree of suppression was inversely proportional to the residual 
ATPase activity of the mutants characterized by Martin et. al. (Martin, Schneider 
et al. 2002). This leads us to porpose a model in which defects in spliceosome 
assembly, like those caused by prp38-1, prompt Spp382p-mediated disassembly 
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of the defective complex via Prp43p.  In a simple model of splicing (Figure 4.1), 
newly synthesized pre-mRNA is either spliced or degraded, with the splicing fate 
favored under optimal conditions. We propose that under normal conditions, 
conformational changes coincident with mRNA formation allow Spp382p to 
stimulate Prp43p recruitment or activation and prompt intron release. When 
splicing is slowed by a mutation, the splicing complex may be dissociated before 
the completion of splicing and the pre-mRNA degraded or reassembled into a 
new spliceosome. I propose that under conditions of limited Spp382p activity the 
discard pathway slows and allows increased opportunity for splicing to occur with 
kinetically impaired splicing mutants such as prp38-1.  
One prediction of this model is that spp382 mutant suppression should not 
be limited to prp38-1 but extend to other (although not necessarily all) mutations 
in the splicing apparatus. Indeed, I found in addition to prp38-1(G66D), spp382 
mutations suppress a second prp38 allele (C87Y) as well as mutations in prp8-2 
and prp19-1. In addition, I recently obtained evidence that spp382-1 can partially 
suppress a weak mutation in the pre-mRNA branchpoint region (UCCUAAC, HZ3 
figure 3.16) and at the 3’ splice site showing that the suppression may extend to 
substrate-level mutations and includes mutants defective in either 
transesterification step in splicing (data not shown). Several other splicing factor 
mutants that I assayed were not suppressed (prp4-1, rds3-1, prp39-1, prp16-1 
and prp22-1). The reasons for lack of suppression are not known but might 
include, for instance, the mutant forming a completely inactive spliceosome 
which would fail to proceed to the next step.  
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Defects in the splicing complex assembly such as those resulting from the 
prp38-1 or prp8-1 mutations might allow for premature Spp382p association or 
activation, resulting in spliceosome disassociation, likely via Prp43p. Consistent 
with this, immune precipitation studies with a TAP-tagged Spp382p indicates that 
this protein recovers an unusual defective splicing complex in which the 5’ exon 
is dissociated. Such defective complexes are known to occur spontaneously in 
vitro and we showed that the levels of defective complexes increase with 
reduced 5’ exon length. Parker and colleagues have provided evidence that such 
defective intermediates of splicing also form in vivo on natural substrates 
(Hilleren and Parker; 2003). While clearly showing Spp382p association, at this 
point we do not know whether exon loss promotes Spp382p binding or simply 
exposes the TAP epitope on a complex where Spp382p was already present. In 
addition, while it is clear that the TAP epitope on Spp382p does not significantly 
inhibit splicing in vivo or in vitro, I cannot rule out a weak defect that might 
contribute to formation of the 5’ exonless complexes that were recovered. 
Intriguingly, while Spp382p binds spliceosomes that lack the upstream exon, 
Prp8p interacts with this upstream exon before lariat formation (Teigelkamp, 
Newman et al. 1995; Teigelkamp, Whittaker et al. 1995) and likely assists in its 
retention afterward (see Grainger and Beggs 2005).  
Several additional lines of evidence support the model of cooperative 
Spp382p-Prp43p function in splicing. For instance, Spp382p and Prp43p interact 
via two hybrid analysis (this study and Tsai, Fu et al. 2005). In addition, I found 
that the prp43R424A mutation (Martin, Schneider et al. 2002) is synthetically 
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lethal with spp382-4 and spp382-6 alleles consistent with an exacerbation of the 
splicing defects. Also, I find that overexpression of Prp43p is sufficient to impair 
the spp382-1 mediated suppression. One possible explanation for this last 
observation could be that the elevated Prp43p levels compensate for possible 
lower affinity mutant spp382-1 gene product (hence restoring the turnover activity 
by mass action). Finally, our lab recently showed that partially purified Spp382p-
complex from yeast extracts, in vitro, dissociates the snRNP-complete 
spliceosome in an ATP-dependant manner. In contrast, the U1/U2 containing 
prespliceosome present in the same mixture is fully resistant to dissociation 
(Rymond, unpublished). While at this point the assay is not selective for 
“defective” spliceosome, the observations are consistent with Spp382p 
association with late-stage splicing complexes and the stimulation of a turnover 
activity. 
  The sedimentation profile of the released intron complex (Martin, 
Schneider et al. 2002) is comparable to that of the nineteen complex (NTC) 
fractions enriched with Spp382p (Wang, Hobbs et al. 2003), consistent with at 
least transient association of Spp382p with late splicing complexes. The Cheng 
lab showed that the affinity purified complex containing Spp382p (called NTR 
complex containing Prp43p and Ntr2p along with Spp382p) is capable of 
disassembling the spliceosome, separating the U2, U6 U5- NTC and the lariat 
intron in vitro (Tsai, Fu et al. 2005). The Beggs lab recently confirmed that 
presence of Spp382p is required for the Prp43p to bind to the post-catalytic 
spliceosome (Boon, Auchynnikava, et al. 2006). Data from the Luhrmann lab 
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suggest that, in vivo, the NTC binds the spliceosome before the activation of the 
spliceosome and remains with the U5 snRNA after the completion of the catalytic 
reactions and disassembly of the spliceosome (Makarov, Makarova et al. 2002). 
Similar results have been observed in yeast (Tarn, Lee et al. 1993; Chan, Kao et 
al. 2003). Although NTC factors act earlier in splicing as reported by our lab 
(Wang, Hobbs et al. 2003).  This 35S U5-NTC snRNP complex that exists after 
splicing has to be disassembled, presumably also by Spp382p dependant 
Prp43p activity. Indeed, we see a small amount of U5 snRNA with purified 
Spp382-TAP (Figure 3.9 C). This is consistent with the presence of a U5 snRNA 
containing post-spliceosomal complex (Makarov, Makarova et al. 2002). Prp8p, a 
U5 snRNP protein, cross links to the 5’ splice site and is implicated in tethering 
the 5’ exon for subsequent steps (Teigelkamp, Newman et al. 1995; Teigelkamp, 
Whittaker et al. 1995; Grainger and Beggs 2005). Both Spp382p and Aar2p, 
another U5 snRNP protein were recently found to be enriched in a complex 
containing mutant version of Prp8p (Boon, Auchynnikava et al. 2006).  
A mutant allele of aar2, aar2-D281N, was also recovered as a suppressor 
of prp38-1. Aar2p is a component of the 16S U5 snRNP along with Prp8p, 
Snu114p and core Sm proteins. The 16S U5 snRNP co-purifies with U1 snRNP 
and this disnRNP particle has been implicated in 5’ splice site recognition 
(Gottschalk, Kastner et al. 2001), suggesting an early co-operative role for U5 
snRNP in the spliceosome assembly, particularly the 5’SS selection. Aar2p, also 
is required for the recycling of splicing factors. Splicing proceeds normally with 
depletion of Aar2p in vitro, unless “multiple turnover” of the spliceosome is 
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required. Under these conditions, extracts depleted of Aar2p fail to splice, 
indicating that Aar2p is necessary when splicing depends on snRNP recycling 
(Gottschalk, Kastner et al. 2001). Splicing factors are recycled to sustain multiple 
rounds of catalysis required for the processing of the abundant intron-bearing 
pre-mRNAs. Hence sequestering factors in dead end spliceosomes has dire 
effects on growth. We speculate that lowering but not abolishing the activity of a 
spliceosome recycling factor allows stalled but partially active spliceosomes 
additional time to splice. The published data are consistent with such a function 
for Aar2p but it is unclear for now whether Aar2p acts via Prp43p- mediated 
disassembly of defective spliceosomes.  
The overexpression of several genes was found to reverse the salutary 
effects of diminished Spp382p activity on splicing mutants. While proteins linked 
by genetics or proteomics to Spp382p or Prp43p (i.e., Cwc23p, Sqs1p) likely 
enhance the recruitment or function of the proposed dissociation complex, it is 
unclear how the remaining effector genes act. In principle, any condition that 
enhances spliceosome disassembly should reduce spp382-1 effectiveness in the 
prp38-1 suppression assay. One can imagine, for instance, that excess levels of 
an early acting splicing factor (e.g., Prp39p (U1 snRNP), or Prp9p (U2 snRNP)) 
might prompt dissociation of a late-acting factor through competition for a 
common protein or RNA binding site. On the other hand, a protein like Dhh1p  
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FIG 4.1. Model of spliceosome integrity (SPIN) surveillance and intron 
release. The model proposes that Spp382p serves a role both in the release of 
correctly spliced intron and in the dissociation of defective spliceosomes. Under 
normal conditions, Spp382p binds (or is exposed on) the spliceosome 
concomitant with the changes bought about by the mRNA being release. This 
event precipitates Prp43p recruitment and intron release. When splicing is 
slowed by a mutation (e.g. prp38-1, prp8-1, or loss of 5’ exon), this allows for 
premature Spp382p association (or exposure), resulting in spliceosome 
disassociation via Prp43p. By extension, decreased Spp382p or Prp43p activity 
is likely to extend the spliceosome stability and therefore the likelihood of 
processing by a partially active complex. Here, the oval bearing the question 
mark represents a factor that normally restricts Spp382p binding (or access) until 
completion of splicing or complex distortion by mutation. 
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 may act via a completely different mechanism through premature pre-RNA 
nuclear export or decay (Coller and Parker 2005) 
The spp382-1 mutation resides within the proposed Ntr2p binding site 
region defined by two hybrid analysis (Uetz, Giot et al. 2000; Ito, Chiba et al. 
2001; Chan, Kao et al. 2003). Here, it is possible that overexpression of Ntr2p 
compensates for a weakened interaction between the two proteins to enhance 
spp382-1p activity on the prp38-1 background. This also would explain how 
overexpression of Ntr2 also suppresses the modest spp382-1 growth defect. 
While challenging, elucidation of the various spp382-1 suppression blocking 
activities acting through gene overexpression may provide insight into the 
processes that influence spliceosome homeostasis. Recently, our lab looked at 
the effect of the overexpression of these proteins had on splicing in the wild type 
strain (data not shown). We found that overexpression of Prp8p, Sqs1p, Cwc23p 
and Spp382p impair splicing while overexpression of other factors did not impact  
splicing, at least for the RPS17a gene. However, we looked at only one time 
point after galactose induction (6 hours), which may have been insufficient to see 
the effect with the rest of the proteins. 
Just as seen with Prp43p overexpression, two other proteins that co-purify 
with Prp43p (Sqs1p/Ynl224c-p, a G patch protein and Cwc23p, a Dna J like 
protein) also inhibit the growth of the spp382-1, prp38-1 double mutant 
suppressed strain when overexpressed. It should be noted that neither one of 
these genes significantly alter growth of wildtype yeast or the spp382-1 or prp38-
1 single mutants when grown on YP-galactose plates. SQS1 overexpression has 
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been reported to impair cell cycle progression (Stevenson, Kennedy et al. 2001) 
and thus impair growth. I confirmed this observation when the assay was done 
on defined medium. Although, Sqs1p is not essential for either robust growth or 
splicing, I do find that overexpression of Sqs1p impairs both splicing and growth 
even in wild type strain. Sqs1p may increase the efficiency of splicing as many 
other non-essential splicing factors do (e.g. Mud2p association helps binding of 
the branchpoint binding protein). Hence it would not be required for splicing per 
se but overexpression might tie up binding partners essential for splicing and 
hence impair their normal function. For some inexplicable reason, we do see a 
difference in the rich vs. selective media.  
Sqs1p, like the Prp43p activator, Spp382p and the Prp2p activator, 
Spp2p, is a G-patch protein. This observation raises the interesting question of 
whether Sqs1p might play a role similar to Spp382p in the recruitment or 
activation of DExD/H box proteins. The splicing defects when overexpressed 
along with two hybrid interaction with Spp382p suggest that it could do so. 
However, alternate models of Sqs1p function are possible- Sqs1p over 
expression might affect splicing indirectly (by inhibiting transcription of core 
splicing factors) or perhaps the “G-patch” of Sqs1p binds with lower affinity core 
splicing factors normally recruited via similar “G-patch” protein and renders them 
non-functional when present in excess amounts.  
My proteomic study shows that Cwc23p co-purifies with Spp382p under 
high stringency, an interaction I confirmed by two hybrid analysis. Cwc23p, like 
Spp382p, is an essential protein whose role in splicing was not characterized 
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prior to this study. Mutational analysis of this protein shows that its J domain is 
important for function. My results demonstrate that Cwc23p mutants show 
impaired splicing and growth. Previous studies with DnaJ proteins in E.coli 
(Hsp40) and in yeast (Ydj1) (Wall, Zylicz et al. 1994; Wall, Zylicz et al. 1995; 
Becker, Walter et al. 1996; Yan and Craig 1999) show that mutations in the J-
domain are either lethal or impair the activity of their Hsp70 partners. In addition, 
in vitro biochemical studies show that the J domain alone is sufficient to stimulate 
the ATPase activity of the Hsp70p similar to that observed with full length DnaJ 
protein (Wall, Zylicz et al. 1994). My results show that the DnaJ domain is also 
important for Cwc23p function and by extrapolation to the published studies, may 
play a role in regulating an ATPase in the spliceosome. This would be exciting 
because Cwc23p is the only known J domain protein in the spliceosome. Since, 
Cwc23p is found in proteomic complexes pulled down using Prp43-TAP (Gavin, 
Bosche et al. 2002; Tsai, Fu et al. 2005) or Spp382-TAP (this study) as bait, it is 
possible that Cwc23p modulates the Prp43 DExD/H -box protein.  
 Primer extension analysis of mRNA isolated from several cwc23 mutants 
reveals an inhibition of the first transesterification step in splicing when Cwc23p 
is inactivated. In addition some Cwc23p mutants also accumulate excess excised 
intron, like Spp382p or Prp43p, suggesting that this protein may play a role in 
recycling of splicing factors. I observed that the cwc23 J-domain mutants fail to 
interact with the Prp43p binding partner Spp382p in the two hybrid assay. 
Although I find no evidence for Prp43p-Cwc23p interaction by two hybrid assay, 
over expression of Cwc23p in the prp43-H218A strain impairs cell growth. This 
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suggests that at least under the conditions tested, too much Cwc23p may 
dampen Prp34p activity. While I found no cases of suppression of other splicing 
mutants by the cwc23 mutants, I found that the prp8-2 mutation suppressed the 
growth impairment of the J domain mutants, cwc23-1 and cwc23-2. Recently 
other prp8 mutant alleles have been shown to suppress either the first step or 
second step splicing defects. The interpretation of the results from many genetic 
experiments is that Prp8p has a role in repositioning the pre-mRNA during the 
transition between the two catalytic steps of splicing (Liu, Query et al. 2007). In 
this light, prp8 mutant could be relieving the cwc23 -1 and cwc23-2 blocked 
spliceosome. 
In addition to its role in splicing, Prp43p plays a critical role in the rRNA 
processing, and is required for production of both the small and the large subunit 
rRNAs. Prp43p can be recovered with the 35S rRNA precursors and all the 
subsequent intermediates (Lebaron, Froment et al. 2005). It is also present in the 
very early pre -60S pre-ribosomal particles. prp43 cold sensitive mutants show 
increased 35S pre-rRNA and depleted levels of 20S, 27S and 7S pre-rRNA 
precursors (Lebaron, Froment et al. 2005; Combs, Nagel et al. 2006; Leeds, 
Small et al. 2006). At the steady state, most Prp43p is found in the nucleolus, the 
site of rRNA biogenesis (Huh, Falvo et al. 2003). Since Prp43p plays a dual role 
in splicing and rRNA biogenesis, it is interesting to speculate on how the protein 
is functionally and physically partitioned. One clue arises from the observation 
that, in addition to binding the Spp382p splicing factor Prp43p interacts with 
Pxr1p, a second G-patch protein required for rRNA biogenesis. Our lab has 
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examined rRNA biogenesis in the spp382 mutant background and could find no 
evidence for this protein acting in the rRNA pathway (data not shown), consistent 
with a specific role in splicing. Conceivably, the alternative G-patch proteins, 
Spp382p and Prx1p, bind Prp43p in a mutually exclusive fashion to direct the 
location and activity of Prp43p. This model is currently under investigation (see 
figure 4.2). 
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FIG. 4.2. Prp43p – Role in spliceosome and ribosome biogenesis. A 
schematic representation of (A) the Prp43p-Spp382p mediated steps (indicated 
with the pink circle) in splicing occurring in the nucleus. The * refers to 
conclusions based on the results of this study. (B) shows Prp43p dependant 
steps in rRNA biogenesis (orange circle) in the nucleolus.  
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Future Directions- 
The results presented here provide strong evidence for a Spp382-
dependant spliceosome integrity (SPIN) complex acting in the discard pathway. 
While our data suggests that the SPIN complex acts to disassemble the 
spliceosome possibly at several stages (Prp38p, Prp8p or Prp19p dependant 
step), it is unclear how the complex recognizes defective substrates and what 
other components make up the SPIN surveillance complex. Based on the 
available genetic and biochemical data, we suspect that Spp382p interactions 
with Prp43p, Cwc23p, Ntr2p and perhaps Sqs1p may contribute to SPIN activity. 
However, it remains to be investigated if there are other proteins that also work 
with Prp43p-Spp382p at this surveillance function. Moreover, the role that 
Cwc23p and Sqs1p play in this complex remains to be understood.  
How the cells target the defective complex and how the surveillance 
complex is kept in check to avoid inappropriate turnover of active spliceosome 
also remains to be addressed. Since the cell regulates protein activity by 
chemical modification (eg. phosphorylation, acetylation, ubiquitination etc), it 
would be interesting to see whether proteins involved in the SPIN complex are 
present with such modifying groups in vivo. It remains to be investigated whether 
SPIN surveillance, the turnover of postcatalytic spliceosomes, and Prp43p 
function in ribosome biogenesis (Lebaron, Froment et al. 2005; Combs, Nagel et 
al. 2006) are accomplished by entities of identical or overlapping protein 
compositions. Since Prp43p interacts with two G-patch proteins, Spp382p (which 
is essential for splicing) and Pxr1p (involved in rRNA biogenesis), it is interesting 
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to speculate whether these two G-patch proteins are responsible for partitioning 
Prp43p between the two separate complexes. Since both Spp2 and Spp382p, 
are now believed to be involved in recruiting the DExD/H box proteins to the 
spliceosome, it will be important to learn how substrate selection is determined 
by these and the other known yeast G-patch proteins  (Pxr1p, Sqs1 and  
Ylr271w-p). 
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Appendix 1. 
Spp381p – Prp38p –Snu23p form a stable heterotrimeric complex. 
 Prp38p is a small (28 kDa), highly acidic tri-snRNP specific protein that is 
required for spliceosome maturation (Blanton, Srinivasan et al. 1992);(Xie, 
Beickman et al. 1998). Prp38p mutants fail to unwind U4/U6 helices, an 
important step for activation of spliceosomes. Prp38p is unlikely to be a helicase 
(based on absence of canonical helicase motifs) but it may act to recruit or 
activate one. The Prp38p mediated release of the U4 snRNA is not well 
understood.  
To begin our study of Prp38p function, we wanted to investigate what this 
protein binds in vivo. We metabolically labeled yeast with 35S-methionine and 
cysteine and purified proteins from a Prp38-TAP strain and an untagged control. 
Purification with Prp38p-TAP pulled showed a heterotrimeric complex. The 
Prp38p protein is associated with two proteins, Spp381p, previously identified as 
a dosage suppressor of prp38-1, (Lybarger, Beickman et al. 1999) and a small 
protein, the same molecular weight as previously identified Snu23p, a tri-snRNP 
protein. To see whether this assignment is true, I purified the complex using 
Prp38-TAP, Spp381-TAP, and Snu23-TAP tagged strains. All three strains 
recover the same three proteins (i.e., Prp38p, Prp381p, Snu23p), as indicated by 
band shifts. The asterix indicates the position of proteins with a residual TAP tag. 
To avoid recovery of complex spliceosomes, two step TAP selection was 
performed at 450 mM NaCl. The proteins were resolved on a polyacrylamide gel 
and, where possible, the tentative protein assignments (based on observed sizes 
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and previous studies) were confirmed by western analysis by using the anti-CBP 
and the anti-Prp38p antibody (data not shown). 
Consistent with the affinity purification results, the three proteins also 
interact by two hybrid assay as shown in table A1.1.  
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FIG A1. Prp38p-Spp381p-Snu23p form stable heterotrimeric complex. 35S- 
labeled proteins from Spp382-TAP, Prp38-TAP, Spp381-TAP or an untagged 
yeast strain were isolated by two step TAP selection at 450 mM NaCl and 
resolved on a polyacrylamide gel. The protein assignments were confirmed by 
western analysis. The CBP indicates the residual tag that remains after TEV 
cleavage. 
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Table A1.1. Two hybrid interactions. The yeast strain PJ69-4a, was co-
transformed with the indicated Gal4p fusion products and growth assayed on 
medium lacking histidine and supplemented with 3 aminotriazole. 
 
pACT 
  
pAS2  Interaction  
Prp38 Spp381 Yes 
Prp38 Snu23 Yes 
Snu23 Spp381 Yes 
Spp381 Snu23 Yes 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Shatakshi Shreekant Pandit 2007 
 171 
 
 
REFERENCES 
Abovich, N. and M. Rosbash (1997). "Cross-intron bridging interactions in the 
yeast commitment complex are conserved in mammals." Cell 89(3): 403-12. 
  
Abu Dayyeh, B. K., T. K. Quan, et al. (2002). "Probing interactions between the 
U2 small nuclear ribonucleoprotein and the DEAD-box protein, Prp5." J Biol 
Chem 277(23): 20221-33. 
  
Altschul, S. F., T. L. Madden, et al. (1997). "Gapped BLAST and PSI-BLAST: a 
new generation of protein database search programs." Nucleic Acids Res 25(17): 
3389-402. 
  
Aravind, L. and E. V. Koonin (1999). "G-patch: a new conserved domain in 
eukaryotic RNA-processing proteins and type D retroviral polyproteins." Trends 
Biochem Sci 24(9): 342-4. 
  
Arenas, J. E. and J. N. Abelson (1997). "Prp43: An RNA helicase-like factor 
involved in spliceosome disassembly." Proc Natl Acad Sci U S A 94(22): 11798-
802. 
  
Becker, J., W. Walter, et al. (1996). "Functional interaction of cytosolic hsp70 and 
a DnaJ-related protein, Ydj1p, in protein translocation in vivo." Mol Cell Biol 
16(8): 4378-86. 
  
Bender, A. and J. R. Pringle (1991). "Use of a screen for synthetic lethal and 
multicopy suppressee mutants to identify two new genes involved in 
morphogenesis in Saccharomyces cerevisiae." Mol Cell Biol 11(3): 1295-305. 
  
Berglund, J. A., N. Abovich, et al. (1998). "A cooperative interaction between 
U2AF65 and mBBP/SF1 facilitates branchpoint region recognition." Genes Dev 
12(6): 858-67. 
  
Blanton, S., A. Srinivasan, et al. (1992). "PRP38 encodes a yeast protein 
required for pre-mRNA splicing and maintenance of stable U6 small nuclear RNA 
levels." Mol Cell Biol 12(9): 3939-47. 
 Abovich, N. and M. Rosbash (1997). "Cross-intron bridging interactions in 
the yeast commitment complex are conserved in mammals." Cell 89(3): 403-12. 
  
Abu Dayyeh, B. K., T. K. Quan, et al. (2002). "Probing interactions between the 
U2 small nuclear ribonucleoprotein and the DEAD-box protein, Prp5." J Biol 
Chem 277(23): 20221-33. 
  
Altschul, S. F., T. L. Madden, et al. (1997). "Gapped BLAST and PSI-BLAST: a 
new generation of protein database search programs." Nucleic Acids Res 25(17): 
3389-402. 
 172 
 
 
  
Aravind, L. and E. V. Koonin (1999). "G-patch: a new conserved domain in 
eukaryotic RNA-processing proteins and type D retroviral polyproteins." Trends 
Biochem Sci 24(9): 342-4. 
  
Arenas, J. E. and J. N. Abelson (1997). "Prp43: An RNA helicase-like factor 
involved in spliceosome disassembly." Proc Natl Acad Sci U S A 94(22): 11798-
802. 
  
Becker, J., W. Walter, et al. (1996). "Functional interaction of cytosolic hsp70 and 
a DnaJ-related protein, Ydj1p, in protein translocation in vivo." Mol Cell Biol 
16(8): 4378-86. 
  
Behzadnia, N., M. M. Golas, et al. (2007). "Composition and three-dimensional 
EM structure of double affinity-purified, human prespliceosomal A complexes." 
Embo J 26(6): 1737-48. 
 
Bender, A. and J. R. Pringle (1991). "Use of a screen for synthetic lethal and 
multicopy suppressee mutants to identify two new genes involved in 
morphogenesis in Saccharomyces cerevisiae." Mol Cell Biol 11(3): 1295-305. 
  
Berglund, J. A., N. Abovich, et al. (1998). "A cooperative interaction between 
U2AF65 and mBBP/SF1 facilitates branchpoint region recognition." Genes Dev 
12(6): 858-67. 
  
Blanton, S., A. Srinivasan, et al. (1992). "PRP38 encodes a yeast protein 
required for pre-mRNA splicing and maintenance of stable U6 small nuclear RNA 
levels." Mol Cell Biol 12(9): 3939-47. 
  
Boeke, J. D., F. LaCroute, et al. (1984). "A positive selection for mutants lacking 
orotidine-5'-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid 
resistance." Mol Gen Genet 197(2): 345-6. 
  
Boon, K. L., T. Auchynnikava, et al. (2006). "Yeast ntr1/spp382 mediates prp43 
function in postspliceosomes." Mol Cell Biol 26(16): 6016-23. 
  
Brow, D. A. (2002). "Allosteric cascade of spliceosome activation." Annu Rev 
Genet 36: 333-60. 
  
Brow, D. A. and C. Guthrie (1988). "Spliceosomal RNA U6 is remarkably 
conserved from yeast to mammals." Nature 334(6179): 213-8. 
  
Burgess, S., J. R. Couto, et al. (1990). "A putative ATP binding protein influences 
the fidelity of branchpoint recognition in yeast splicing." Cell 60(5): 705-17. 
  
 173 
 
 
Burgess, S. M. and C. Guthrie (1993). "A mechanism to enhance mRNA splicing 
fidelity: the RNA-dependent ATPase Prp16 governs usage of a discard pathway 
for aberrant lariat intermediates." Cell 73(7): 1377-91. 
  
Chan, S. P. and S. C. Cheng (2005). "The Prp19-associated complex is required 
for specifying interactions of U5 and U6 with pre-mRNA during spliceosome 
activation." J Biol Chem 280(35): 31190-9. 
  
Chan, S. P., D. I. Kao, et al. (2003). "The Prp19p-associated complex in 
spliceosome activation." Science 302(5643): 279-82. 
  
Chapman, K. B. and J. D. Boeke (1991). "Isolation and characterization of the 
gene encoding yeast debranching enzyme." Cell 65(3): 483-92. 
  
Chen, C. H., W. C. Yu, et al. (2002). "Functional and physical interactions 
between components of the Prp19p-associated complex." Nucleic Acids Res 
30(4): 1029-37. 
  
Chen, E. J., A. R. Frand, et al. (1998). "A link between secretion and pre-mRNA 
processing defects in Saccharomyces cerevisiae and the identification of a novel 
splicing gene, RSE1." Mol Cell Biol 18(12): 7139-46. 
  
Chen, J. Y., L. Stands, et al. (2001). "Specific alterations of U1-C protein or U1 
small nuclear RNA can eliminate the requirement of Prp28p, an essential DEAD 
box splicing factor." Mol Cell 7(1): 227-32. 
  
Cheng, S. C. and J. Abelson (1987). "Spliceosome assembly in yeast." Genes 
Dev 1(9): 1014-27. 
  
Coller, J. and R. Parker (2005). "General translational repression by activators of 
mRNA decapping." Cell 122(6): 875-86. 
  
Collins, C. A. and C. Guthrie (1999). "Allele-specific genetic interactions between 
Prp8 and RNA active site residues suggest a function for Prp8 at the catalytic 
core of the spliceosome." Genes Dev 13(15): 1970-82. 
  
Combs, D. J., R. J. Nagel, et al. (2006). "Prp43p is a DEAH-box spliceosome 
disassembly factor essential for ribosome biogenesis." Mol Cell Biol 26(2): 523-
34. 
  
Couto, J. R., J. Tamm, et al. (1987). "A trans-acting suppressor restores splicing 
of a yeast intron with a branch point mutation." Genes Dev 1(5): 445-55. 
  
Cold Spring Harbor Methods in Yeast Genetics, 1994, pages 211-212. 
 174 
 
 
Deckert, J., K. Hartmuth, et al. (2006). "Protein composition and electron 
microscopy structure of affinity-purified human spliceosomal B complexes 
isolated under physiological conditions." Mol Cell Biol 26(14): 5528-43. 
Fabrizio, P. and J. Abelson (1990). "Two domains of yeast U6 small nuclear RNA 
required for both steps of nuclear precursor messenger RNA splicing." Science 
250(4979): 404-9. 
  
Fabrizio, P., B. Laggerbauer, et al. (1997). "An evolutionarily conserved U5 
snRNP-specific protein is a GTP-binding factor closely related to the ribosomal 
translocase EF-2." Embo J 16(13): 4092-106. 
 
Fleckner, J., M. Zhang, et al. (1997). "U2AF65 recruits a novel human DEAD box 
protein required for the U2 snRNP-branchpoint interaction." Genes Dev 11(14): 
1864-72. 
  
Gavin, A. C., M. Bosche, et al. (2002). "Functional organization of the yeast 
proteome by systematic analysis of protein complexes." Nature 415(6868): 141-
7. 
  
Giaever, G., A. M. Chu, et al. (2002). "Functional profiling of the Saccharomyces 
cerevisiae genome." Nature 418(6896): 387-91. 
  
Gietz, R. D. and A. Sugino (1988). "New yeast-Escherichia coli shuttle vectors 
constructed with in vitro mutagenized yeast genes lacking six-base pair 
restriction sites." Gene 74(2): 527-34. 
  
Gornemann, J., K. M. Kotovic, et al. (2005). "Cotranscriptional spliceosome 
assembly occurs in a stepwise fashion and requires the cap binding complex." 
Mol Cell 19(1): 53-63. 
  
Gottschalk, A., B. Kastner, et al. (2001). "The yeast U5 snRNP coisolated with 
the U1 snRNP has an unexpected protein composition and includes the splicing 
factor Aar2p." Rna 7(11): 1554-65. 
  
Grainger, R. J. and J. D. Beggs (2005). "Prp8 protein: at the heart of the 
spliceosome." Rna 11(5): 533-57. 
  
Guthrie, C. and B. Patterson (1988). "Spliceosomal snRNAs." Annu Rev Genet 
22: 387-419. 
  
Hall, S. L. and R. A. Padgett (1994). "Conserved sequences in a class of rare 
eukaryotic nuclear introns with non-consensus splice sites." J Mol Biol 239(3): 
357-65. 
  
Hastings, M. L. and A. R. Krainer (2001). "Pre-mRNA splicing in the new 
millennium." Curr Opin Cell Biol 13(3): 302-9. 
 175 
 
 
  
Herrmann, G., S. Kais, et al. (2007). "Conserved interactions of the splicing factor 
Ntr1/Spp382 with proteins involved in DNA double-strand break repair and 
telomere metabolism." Nucleic Acids Res 35(7): 2321-32. 
  
Huh, W. K., J. V. Falvo, et al. (2003). "Global analysis of protein localization in 
budding yeast." Nature 425(6959): 686-91. 
  
Igel, A. H. and M. Ares, Jr. (1988). "Internal sequences that distinguish yeast 
from metazoan U2 snRNA are unnecessary for pre-mRNA splicing." Nature 
334(6181): 450-3. 
  
Ito, T., T. Chiba, et al. (2001). "A comprehensive two-hybrid analysis to explore 
the yeast protein interactome." Proc Natl Acad Sci U S A 98(8): 4569-74. 
  
Jacquier, A., J. R. Rodriguez, et al. (1985). "A quantitative analysis of the effects 
of 5' junction and TACTAAC box mutants and mutant combinations on yeast 
mRNA splicing." Cell 43(2 Pt 1): 423-30. 
  
Jacquier, A. and M. Rosbash (1986). "RNA splicing and intron turnover are 
greatly diminished by a mutant yeast branch point." Proc Natl Acad Sci U S A 
83(16): 5835-9. 
  
James, P., J. Halladay, et al. (1996). "Genomic libraries and a host strain 
designed for highly efficient two-hybrid selection in yeast." Genetics 144(4): 
1425-36. 
  
Kabeya, Y., Y. Kamada, et al. (2005). "Atg17 functions in cooperation with Atg1 
and Atg13 in yeast autophagy." Mol Biol Cell 16(5): 2544-53. 
  
Kim, C. H. and J. Abelson (1996). "Site-specific crosslinks of yeast U6 snRNA to 
the pre-mRNA near the 5' splice site." Rna 2(10): 995-1010. 
  
Kim, D. H. and J. J. Rossi (1999). "The first ATPase domain of the yeast 246-kDa 
protein is required for in vivo unwinding of the U4/U6 duplex." Rna 5(7): 959-71. 
  
Kistler, A. L. and C. Guthrie (2001). "Deletion of MUD2, the yeast homolog of 
U2AF65, can bypass the requirement for sub2, an essential spliceosomal 
ATPase." Genes Dev 15(1): 42-9. 
  
Konarska, M. M. and C. C. Query (2005). "Insights into the mechanisms of 
splicing: more lessons from the ribosome." Genes Dev 19(19): 2255-60. 
  
Konarska, M. M. and P. A. Sharp (1986). "Electrophoretic separation of 
complexes involved in the splicing of precursors to mRNAs." Cell 46(6): 845-55. 
  
 176 
 
 
Lacadie, S. A. and M. Rosbash (2005). "Cotranscriptional spliceosome assembly 
dynamics and the role of U1 snRNA:5'ss base pairing in yeast." Mol Cell 19(1): 
65-75. 
  
Lebaron, S., C. Froment, et al. (2005). "The splicing ATPase prp43p is a 
component of multiple preribosomal particles." Mol Cell Biol 25(21): 9269-82. 
  
Leeds, N. B., E. C. Small, et al. (2006). "The splicing factor Prp43p, a DEAH box 
ATPase, functions in ribosome biogenesis." Mol Cell Biol 26(2): 513-22. 
  
Legrain, P., B. Seraphin, et al. (1988). "Early commitment of yeast pre-mRNA to 
the spliceosome pathway." Mol Cell Biol 8(9): 3755-60. 
  
Lesser, C. F. and C. Guthrie (1993). "Mutations in U6 snRNA that alter splice site 
specificity: implications for the active site." Science 262(5142): 1982-8. 
  
Li, Z. and D. A. Brow (1996). "A spontaneous duplication in U6 spliceosomal 
RNA uncouples the early and late functions of the ACAGA element in vivo." Rna 
2(9): 879-94. 
  
Lin, J. and J. J. Rossi (1996). "Identification and characterization of yeast 
mutants that overcome an experimentally introduced block to splicing at the 3' 
splice site." Rna 2(8): 835-48. 
  
Linder, P. ( 2006). "Dead-box proteins: a family affair—active and passive 
players in RNP-remodeling." Nucleic Acids Res. 34(15): 4168–4180. 
  
Liu, L., C. C. Query, et al. (2007). "Opposing classes of prp8 alleles modulate the 
transition between the catalytic steps of pre-mRNA splicing." Nat Struct Mol Biol 
14(6): 519-26. 
  
Lockhart, S. R. and B. C. Rymond (1994). "Commitment of yeast pre-mRNA to 
the splicing pathway requires a novel U1 small nuclear ribonucleoprotein 
polypeptide, Prp39p." Mol Cell Biol 14(6): 3623-33. 
  
Lybarger, S., K. Beickman, et al. (1999). "Elevated levels of a U4/U6.U5 snRNP-
associated protein, Spp381p, rescue a mutant defective in spliceosome 
maturation." Mol Cell Biol 19(1): 577-84. 
  
Madhani, H. D., R. Bordonne, et al. (1990). "Multiple roles for U6 snRNA in the 
splicing pathway." Genes Dev 4(12B): 2264-77. 
  
Makarov, E. M., O. V. Makarova, et al. (2002). "Small nuclear ribonucleoprotein 
remodeling during catalytic activation of the spliceosome." Science 298(5601): 
2205-8. 
  
 177 
 
 
Makarova, O. V., E. M. Makarov, et al. (2004). "A subset of human 35S U5 
proteins, including Prp19, function prior to catalytic step 1 of splicing." Embo J 
23(12): 2381-91. 
  
Martin, A., S. Schneider, et al. (2002). "Prp43 is an essential RNA-dependent 
ATPase required for release of lariat-intron from the spliceosome." J Biol Chem 
277(20): 17743-50. 
  
Mayas, R. M., H. Maita, et al. (2006). "Exon ligation is proofread by the DExD/H-
box ATPase Prp22p." Nat Struct Mol Biol 13(6): 482-90. 
  
Mumberg, D., R. Muller, et al. (1994). "Regulatable promoters of Saccharomyces 
cerevisiae: comparison of transcriptional activity and their use for heterologous 
expression." Nucleic Acids Res 22(25): 5767-8. 
  
Newman, A. J., S. Teigelkamp, et al. (1995). "snRNA interactions at 5' and 3' 
splice sites monitored by photoactivated crosslinking in yeast spliceosomes." 
Rna 1(9): 968-80. 
  
Ohi, M. D., A. J. Link, et al. (2002). "Proteomics analysis reveals stable 
multiprotein complexes in both fission and budding yeasts containing Myb-related 
Cdc5p/Cef1p, novel pre-mRNA splicing factors, and snRNAs." Mol Cell Biol 
22(7): 2011-24. 
  
Patel, A. A., M. McCarthy, et al. (2002). "The splicing of U12-type introns can be 
a rate-limiting step in gene expression." Embo J 21(14): 3804-15. 
  
Patterson, B. and C. Guthrie (1991). "A U-rich tract enhances usage of an 
alternative 3' splice site in yeast." Cell 64(1): 181-7. 
  
Perriman, R. and M. Ares, Jr. (2000). "ATP can be dispensable for 
prespliceosome formation in yeast." Genes Dev 14(1): 97-107. 
  
Perriman, R., I. Barta, et al. (2003). "ATP requirement for Prp5p function is 
determined by Cus2p and the structure of U2 small nuclear RNA." Proc Natl 
Acad Sci U S A 100(24): 13857-62. 
  
Perriman, R. J. and M. Ares, Jr. (2007). "Rearrangement of competing U2 RNA 
helices within the spliceosome promotes multiple steps in splicing." Genes Dev 
21(7): 811-20. 
  
Philips, A. V. and T. A. Cooper (2000). "RNA processing and human disease." 
Cell Mol Life Sci 57(2): 235-49. 
  
 178 
 
 
Pikielny, C. W., B. C. Rymond, et al. (1986). "Electrophoresis of 
ribonucleoproteins reveals an ordered assembly pathway of yeast splicing 
complexes." Nature 324(6095): 341-5. 
  
Plumpton, M., M. McGarvey, et al. (1994). "A dominant negative mutation in the 
conserved RNA helicase motif 'SAT' causes splicing factor PRP2 to stall in 
spliceosomes." Embo J 13(4): 879-87. 
  
Puig, O., F. Caspary, et al. (2001). "The tandem affinity purification (TAP) 
method: a general procedure of protein complex purification." Methods 24(3): 
218-29. 
  
Query, C. C. and M. M. Konarska (2004). "Suppression of multiple substrate 
mutations by spliceosomal prp8 alleles suggests functional correlations with 
ribosomal ambiguity mutants." Mol Cell 14(3): 343-54. 
  
Query, C. C. and M. M. Konarska (2006). "Splicing fidelity revisited." Nat Struct 
Mol Biol 13(6): 472-4. 
  
Raghunathan, P. L. and C. Guthrie (1998). "RNA unwinding in U4/U6 snRNPs 
requires ATP hydrolysis and the DEIH-box splicing factor Brr2." Curr Biol 8(15): 
847-55. 
  
Rosbash, M. and B. Seraphin (1991). "Who's on first? The U1 snRNP-5' splice 
site interaction and splicing." Trends Biochem Sci 16(5): 187-90. 
  
Rose, M. D., P. Novick, et al. (1987). "A Saccharomyces cerevisiae genomic 
plasmid bank based on a centromere-containing shuttle vector." Gene 60(2-3): 
237-43. 
  
Roy, J., K. Kim, et al. (1995). "The final stages of spliceosome maturation require 
Spp2p that can interact with the DEAH box protein Prp2p and promote step 1 of 
splicing." Rna 1(4): 375-90. 
  
Rymond, B. C., C. Pikielny, et al. (1990). "Measurement and analysis of yeast 
pre-mRNA sequence contribution to splicing efficiency." Methods Enzymol 181: 
122-47. 
  
Rymond, B. C. and M. Rosbash (1985). "Cleavage of 5' splice site and lariat 
formation are independent of 3' splice site in yeast mRNA splicing." Nature 
317(6039): 735-7. 
  
Sahi, C. and E. A. Craig (2007). "Network of general and specialty J protein 
chaperones of the yeast cytosol." Proc Natl Acad Sci U S A 104(17): 7163-8. 
  
 179 
 
 
Sambrook K. J., Fritsch E. f., et al. (1989). Molecular Cloning- A laboratory 
manual, Cold Spring Harbor Press. 
  
Sawa, H. and J. Abelson (1992). "Evidence for a base-pairing interaction 
between U6 small nuclear RNA and 5' splice site during the splicing reaction in 
yeast." Proc Natl Acad Sci U S A 89(23): 11269-73. 
  
Schwer, B. and C. H. Gross (1998). "Prp22, a DExH-box RNA helicase, plays 
two distinct roles in yeast pre-mRNA splicing." Embo J 17(7): 2086-94. 
  
Schwer, B. and C. Guthrie (1992). "A conformational rearrangement in the 
spliceosome is dependent on PRP16 and ATP hydrolysis." Embo J 11(13): 5033-
9. 
  
Seraphin, B. and M. Rosbash (1989). "Identification of functional U1 snRNA-pre-
mRNA complexes committed to spliceosome assembly and splicing." Cell 59(2): 
349-58. 
  
Sherman F., Finks G. R., et al. (1986). Laboratory course manual for methods in 
Yeast genetics, Cold Spring Harbor Press. 
  
Shuster, E. O. and C. Guthrie (1988). "Two conserved domains of yeast U2 
snRNA are separated by 945 nonessential nucleotides." Cell 55(1): 41-8. 
  
Siliciano, P. G., D. A. Brow, et al. (1987). "An essential snRNA from S. cerevisiae 
has properties predicted for U4, including interaction with a U6-like snRNA." Cell 
50(4): 585-92. 
  
Silverman, E. J., A. Maeda, et al. (2004). "Interaction between a G-patch protein 
and a spliceosomal DEXD/H-box ATPase that is critical for splicing." Mol Cell Biol 
24(23): 10101-10. 
  
Small, E. C., S. R. Leggett, et al. (2006). "The EF-G-like GTPase Snu114p 
regulates spliceosome dynamics mediated by Brr2p, a DExD/H box ATPase." 
Mol Cell 23(3): 389-99. 
  
Sontheimer, E. J. and J. A. Steitz (1993). "The U5 and U6 small nuclear RNAs as 
active site components of the spliceosome." Science 262(5142): 1989-96. 
  
Spingola, M., L. Grate, et al. (1999). "Genome-wide bioinformatic and molecular 
analysis of introns in Saccharomyces cerevisiae." Rna 5(2): 221-34. 
  
Staley, J. P. and C. Guthrie (1998). "Mechanical devices of the spliceosome: 
motors, clocks, springs, and things." Cell 92(3): 315-26. 
  
 180 
 
 
Stevens, S. W. and J. Abelson (2002). "Yeast pre-mRNA splicing: methods, 
mechanisms, and machinery." Methods Enzymol 351: 200-20. 
  
Stevens, S. W., I. Barta, et al. (2001). "Biochemical and genetic analyses of the 
U5, U6, and U4/U6 x U5 small nuclear ribonucleoproteins from Saccharomyces 
cerevisiae." Rna 7(11): 1543-53. 
  
Stevens, S. W., D. E. Ryan, et al. (2002). "Composition and functional 
characterization of the yeast spliceosomal penta-snRNP." Mol Cell 9(1): 31-44. 
  
Stevenson, L. F., B. K. Kennedy, et al. (2001). "A large-scale overexpression 
screen in Saccharomyces cerevisiae identifies previously uncharacterized cell 
cycle genes." Proc Natl Acad Sci U S A 98(7): 3946-51. 
  
Tanner N.K., Cordin O., et al. (2003). "The Q motif. A newly identified motif in 
DEAD box helicases may regulate ATP binding and hydrolysis." Mol. Cell. 11: 
127–138. 
  
Tarn, W. Y., K. R. Lee, et al. (1993). "Yeast precursor mRNA processing protein 
PRP19 associates with the spliceosome concomitant with or just after 
dissociation of U4 small nuclear RNA." Proc Natl Acad Sci U S A 90(22): 10821-
5. 
  
Tarn, W. Y. and J. A. Steitz (1997). "Pre-mRNA splicing: the discovery of a new 
spliceosome doubles the challenge." Trends Biochem Sci 22(4): 132-7. 
  
Teem, J. L. and M. Rosbash (1983). "Expression of a beta-galactosidase gene 
containing the ribosomal protein 51 intron is sensitive to the rna2 mutation of 
yeast." Proc Natl Acad Sci U S A 80(14): 4403-7. 
  
Teigelkamp, S., M. McGarvey, et al. (1994). "The splicing factor PRP2, a putative 
RNA helicase, interacts directly with pre-mRNA." Embo J 13(4): 888-97. 
  
Teigelkamp, S., A. J. Newman, et al. (1995). "Extensive interactions of PRP8 
protein with the 5' and 3' splice sites during splicing suggest a role in stabilization 
of exon alignment by U5 snRNA." Embo J 14(11): 2602-12. 
  
Teigelkamp, S., E. Whittaker, et al. (1995). "Interaction of the yeast splicing factor 
PRP8 with substrate RNA during both steps of splicing." Nucleic Acids Res 23(3): 
320-6. 
  
Tsai, R. T., R. H. Fu, et al. (2005). "Spliceosome disassembly catalyzed by Prp43 
and its associated components Ntr1 and Ntr2." Genes Dev 19(24): 2991-3003. 
  
 181 
 
 
Tsai, W. Y., Y. T. Chow, et al. (1999). "Cef1p is a component of the Prp19p-
associated complex and essential for pre-mRNA splicing." J Biol Chem 274(14): 
9455-62. 
  
Uetz, P., L. Giot, et al. (2000). "A comprehensive analysis of protein-protein 
interactions in Saccharomyces cerevisiae." Nature 403(6770): 623-7. 
  
Umen, J. G. and C. Guthrie (1995). "Prp16p, Slu7p, and Prp8p interact with the 
3' splice site in two distinct stages during the second catalytic step of pre-mRNA 
splicing." Rna 1(6): 584-97. 
  
Umen, J. G. and C. Guthrie (1996). "Mutagenesis of the yeast gene PRP8 
reveals domains governing the specificity and fidelity of 3' splice site selection." 
Genetics 143(2): 723-39. 
  
Valcarcel, J. and M. R. Green (1996). "The SR protein family: pleiotropic 
functions in pre-mRNA splicing." Trends Biochem Sci 21(8): 296-301. 
  
van Nues, R. W. and J. D. Beggs (2001). "Functional contacts with a range of 
splicing proteins suggest a central role for Brr2p in the dynamic control of the 
order of events in spliceosomes of Saccharomyces cerevisiae." Genetics 157(4): 
1451-67. 
  
Wagner, J. D., E. Jankowsky, et al. (1998). "The DEAH-box protein PRP22 is an 
ATPase that mediates ATP-dependent mRNA release from the spliceosome and 
unwinds RNA duplexes." Embo J 17(10): 2926-37. 
  
Wall, D., M. Zylicz, et al. (1994). "The NH2-terminal 108 amino acids of the 
Escherichia coli DnaJ protein stimulate the ATPase activity of DnaK and are 
sufficient for lambda replication." J Biol Chem 269(7): 5446-51. 
  
Wall, D., M. Zylicz, et al. (1995). "The conserved G/F motif of the DnaJ 
chaperone is necessary for the activation of the substrate binding properties of 
the DnaK chaperone." J Biol Chem 270(5): 2139-44. 
  
Walsh, P., D. Bursac, et al. (2004). "The J-protein family: modulating protein 
assembly, disassembly and translocation." EMBO Rep 5(6): 567-71. 
  
Wang, Q., J. He, et al. (2005). "Interactions of the yeast SF3b splicing factor." 
Mol Cell Biol 25(24): 10745-54. 
  
Wang, Q., K. Hobbs, et al. (2003). "The Clf1p splicing factor promotes 
spliceosome assembly through N-terminal tetratricopeptide repeat contacts." J 
Biol Chem 278(10): 7875-83. 
  
 182 
 
 
Wang, Q. and B. C. Rymond (2003). "Rds3p is required for stable U2 snRNP 
recruitment to the splicing apparatus." Mol Cell Biol 23(20): 7339-49. 
  
Wells, S. E. and M. Ares, Jr. (1994). "Interactions between highly conserved U2 
small nuclear RNA structures and Prp5p, Prp9p, Prp11p, and Prp21p proteins 
are required to ensure integrity of the U2 small nuclear ribonucleoprotein in 
Saccharomyces cerevisiae." Mol Cell Biol 14(9): 6337-49. 
  
Winzeler, E. A., D. D. Shoemaker, et al. (1999). "Functional characterization of 
the S. cerevisiae genome by gene deletion and parallel analysis." Science 
285(5429): 901-6. 
  
Xie, J., K. Beickman, et al. (1998). "Progression through the spliceosome cycle 
requires Prp38p function for U4/U6 snRNA dissociation." Embo J 17(10): 2938-
46. 
  
Xu, Y. Z., C. M. Newnham, et al. (2004). "Prp5 bridges U1 and U2 snRNPs and 
enables stable U2 snRNP association with intron RNA." Embo J 23(2): 376-85. 
  
Yan, W. and E. A. Craig (1999). "The glycine-phenylalanine-rich region 
determines the specificity of the yeast Hsp40 Sis1." Mol Cell Biol 19(11): 7751-8. 
  
Yean, S. L. and R. J. Lin (1991). "U4 small nuclear RNA dissociates from a yeast 
spliceosome and does not participate in the subsequent splicing reaction." Mol 
Cell Biol 11(11): 5571-7. 
  
Zhang, D. and M. Rosbash (1999). "Identification of eight proteins that cross-link 
to pre-mRNA in the yeast commitment complex." Genes Dev 13(5): 581-92. 
  
 
 
Copyright © Shatakshi Shreekant Pandit 2007 
 
 
 183 
 
 
VITA 
Shatakshi Shreekant Pandit 
Born: 1975, Nasik, India 
 
Education: 
• University Of Kentucky    August 2001- present 
           Doctoral Program(Biology) 
           Specialization – Molecular Biology. 
• University of Mumbai    1996-1998 
           Master of Science (Technology) 
           Specialization- Bioprocess Technology 
• University Of Pune    1992-1996 
            Bachelor in Pharmacy 
 
Scholastic Honors 
Fellowship for Academic Excellence    2004-2005 
Ribble Research Fellowship     2002 
UGC fellowship (India)     1996-1998 
 
Publication 
Pandit, S., Lynn, B. and Rymond, B.C., (2006). "Inhibition of a spliceosome 
turnover pathway suppresses splicing defects." Proc Natl Acad Sci U S A 
103(37): 13700-5. 
 184 
 
 
 
 185 
 
 
